Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3013201	s-b2miglo	mg/l (mg/l)	2797	5069	0.00%
3013201	s-b2miglo	— (—)	263	423	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Enlarged lymph nodes

347

327

11.05

321.28

1.5

2.1

3.43

3.80

mg/l

0.81

336

310

Malignant neoplasm, wide definition for exclusion

852

906

5.59

307.65

2.1

1.5

3.63

3.29

mg/l

1.09

810

863

Second line medication for Crohn's disease

813

1521

5.46

307.65

2.9

1.5

3.79

3.68

mg/l

0.26

781

1447

Primary_lymphoid and hematopoietic malignant neoplasms

1531

310

57.20

307.65

2.2

1.5

4.13

3.88

mg/l

0.43

1460

293

Liquid cancers, helper endpoint

1852

358

49.80

307.65

2.0

1.5

4.00

3.69

mg/l

0.64

1754

339

ILD medications

1077

1363

4.33

307.65

2.2

1.5

3.96

3.44

mg/l

2.43

1028

1291

First line medication for Crohn's disease

1039

1290

4.40

307.65

2.2

1.4

4.10

3.34

mg/l

4.22

983

1226

Malignant neoplasm

911

886

6.17

307.65

2.1

1.5

3.60

3.29

mg/l

0.99

868

844

Non-Hodgkin lymphoma, all, including Hilmo

413

162

27.40

307.65

1.6

1.4

3.75

4.25

mg/l

0.60

396

155

L04AX Other immunosuppressants

806

1491

5.52

307.65

2.9

1.5

3.81

3.64

mg/l

0.43

774

1418

Fever of other and unknown origin

745

1127

5.99

307.65

2.2

1.9

4.03

3.69

mg/l

0.97

707

1071

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1156

1653

4.90

307.65

1.8

1.9

4.34

3.31

mg/l

8.35

1094

1580

ILD medications: immunosuppressive drugs

942

1234

7.25

307.65

2.7

1.5

3.97

3.35

mg/l

3.11

906

1174

Secondary uncertain malignant neoplasm

251

161

16.25

293.00

1.6

1.4

3.67

4.48

mg/l

0.99

242

154

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

248

179

14.36

271.19

1.6

1.4

3.57

4.24

mg/l

0.92

239

170

Any event in cancer register

831

1139

4.34

266.20

2.0

1.8

3.58

3.33

mg/l

0.75

784

1090

Non-follicular lymphoma

281

260

11.58

264.89

1.7

1.8

4.06

4.57

mg/l

0.83

268

249

Bacterial infection, other or unspecified

689

1341

4.42

257.11

2.2

1.7

4.67

3.47

mg/l

6.94

647

1278

Bacterial infection, other or unspecified

655

1276

4.53

254.45

2.2

1.7

4.68

3.54

mg/l

5.76

617

1215

Sicca syndrome [Sjögren]

249

208

12.81

250.84

2.3

1.8

2.96

4.09

mg/l

2.72

239

202

Other systemic involvement of connective tissue (FG)

411

637

6.54

248.11

2.1

1.7

3.18

3.94

mg/l

2.91

394

600

Other diseases of blood and blood-forming organs, wide

394

619

6.58

239.42

1.7

1.9

3.99

4.15

mg/l

0.25

370

592

Systemic connective tissue disorders

491

978

5.14

231.27

2.1

1.8

3.25

4.14

mg/l

4.57

470

929

Other bacterial diseases

907

1769

3.48

228.52

2.1

1.7

4.70

3.30

mg/l

10.86

861

1688

Aplastic and other anaemias

580

1244

4.43

223.88

1.9

1.8

5.06

3.86

mg/l

5.38

545

1178

Other systemic involvement of connective tissue

414

760

5.59

213.92

2.2

1.8

3.18

4.13

mg/l

4.45

397

719

Other and unspecified anaemias

538

1160

4.51

213.72

2.0

1.7

5.04

3.94

mg/l

4.32

506

1097

Other anaemias

540

1169

4.48

212.57

2.0

1.7

5.04

3.93

mg/l

4.37

508

1106

ILD medications: prednisolone, methylprednisolone, prednisone

857

1354

3.57

209.78

1.8

1.5

3.99

3.45

mg/l

2.28

807

1283

Other bacterial diseases

885

1759

3.22

194.65

2.1

1.7

4.48

3.21

mg/l

10.24

839

1681

Transplanted organ and tissue status

222

234

9.97

190.19

3.2

1.9

4.45

3.83

mg/l

0.67

216

227

General symptoms and signs

835

1267

3.33

177.34

1.8

3.84

3.56

mg/l

0.79

788

1205

Neoplasms

480

510

5.02

172.64

1.9

1.7

3.93

3.04

mg/l

2.64

460

486

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

759

1415

3.28

168.82

2.4

1.5

4.36

3.35

mg/l

5.84

727

1354

759

1415

3.28

168.82

2.4

1.5

4.36

3.35

mg/l

5.84

727

1354

Oxycodone

456

995

4.22

164.14

2.5

1.7

4.26

3.86

mg/l

0.91

439

943

Influenza and pneumonia

857

1873

2.93

161.92

2.5

1.6

4.26

3.31

mg/l

6.28

818

1788

Pneumonias (Asthma/COPD co-morbidities)

823

1896

2.94

158.62

2.4

1.6

4.48

3.29

mg/l

7.86

786

1807

All pneumoniae

822

1917

2.89

153.65

2.4

1.6

4.47

3.31

mg/l

7.52

786

1827

Pneumonia, organism unspecified

739

1794

2.91

142.07

2.4

1.6

4.63

3.35

mg/l

7.68

701

1712

Oral corticosteroids

853

1849

2.76

141.63

1.8

3.76

3.72

mg/l

0.08

801

1772

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

779

1950

2.75

133.74

2.4

1.6

4.55

3.32

mg/l

7.77

740

1861

Agranulocytosis

192

272

7.32

128.88

1.9

4.00

4.46

mg/l

0.58

183

265

Any gastric operation

505

686

3.72

125.45

1.8

1.7

4.05

3.03

mg/l

4.44

478

658

GASTRO-related operations

505

686

3.72

125.45

1.8

1.7

4.05

3.03

mg/l

4.44

478

658

Septicaemia

410

1056

3.68

124.03

2.2

1.7

5.57

3.63

mg/l

7.17

387

1002

Dental caries

282

585

4.71

119.32

3.0

1.8

4.81

3.72

mg/l

2.07

273

558

Inflammatory bowel disease treatment related agents

848

1876

2.54

118.92

1.8

3.76

3.71

mg/l

0.10

797

1796

Explicit Sepsis

431

1179

3.46

118.69

2.2

1.8

5.48

3.42

mg/l

8.87

408

1120

Caries of dentine

259

516

4.97

117.16

3.1

1.8

4.87

3.64

mg/l

2.28

251

491

Solid cancers, helper endpoint

500

879

3.38

116.08

1.7

1.5

3.61

3.31

mg/l

0.75

477

837

Other medical care

450

1244

3.29

113.75

2.1

1.8

4.33

3.46

mg/l

3.49

424

1173

Renal failure

458

1278

3.21

110.47

2.2

1.8

8.66

3.18

mg/l

35.82

432

1207

Autoimmune diseases related-to ILD

660

2176

2.61

109.44

1.9

1.8

3.33

3.83

mg/l

2.49

623

2075

Autoimmune diseases excluding thyroid diseases

765

1653

2.54

106.30

1.8

1.9

3.51

3.77

mg/l

0.85

722

1577

Infections, IBD-co-morbidities

185

189

7.11

105.40

2.6

1.6

5.11

3.12

mg/l

3.52

171

181

Purpura and other haemorrhagic conditions

192

338

5.84

104.10

1.9

1.8

4.39

4.57

mg/l

0.14

181

325

All chronic kidney diseases

479

1309

3.02

102.67

2.1

1.8

8.02

2.93

mg/l

34.02

453

1242

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

148

204

7.55

101.99

1.7

1.9

3.54

4.42

mg/l

1.96

139

196

Coagulation defects, purpura and other haemorrhagic conditions

237

516

4.69

100.72

1.9

4.09

4.24

mg/l

0.15

223

493

COPD/asthma related infections

723

1415

2.57

100.27

2.2

1.5

4.19

3.35

mg/l

4.37

684

1354

COPD/asthma/ILD related infections

723

1415

2.57

100.27

2.2

1.5

4.19

3.35

mg/l

4.37

684

1354

Renal tubulo-interstitial diseases

673

2014

2.51

99.18

2.1

1.8

6.72

2.84

mg/l

35.66

638

1915

Covid-19 confirmed case

357

1055

3.43

98.93

2.1

1.8

4.50

4.07

mg/l

0.87

344

989

Persons encountering health services for specific procedures and health care

763

1903

2.42

98.59

2.0

1.8

4.64

3.16

mg/l

10.03

730

1803

Autoimmune diseases excluding thyroid diseases, strict definition

729

1606

2.50

98.32

1.8

1.9

3.55

3.77

mg/l

0.61

686

1532

Bacterial Sepsis

428

1187

3.12

97.68

2.1

1.8

6.00

3.48

mg/l

11.37

405

1129

Mixed connective tissue disease

126

156

8.45

95.28

2.2

1.8

2.98

3.76

mg/l

1.48

121

149

Any reimbursement code in KELA

318

371

4.32

95.21

1.9

1.4

3.87

2.28

mg/l

6.54

305

354

Finngen Rheumatological endpoints

671

1507

2.55

95.06

2.0

1.8

3.61

3.67

mg/l

0.12

640

1432

All kidney diseases

710

2027

2.41

94.26

2.0

1.8

5.85

2.76

mg/l

30.02

678

1931

Polyarthropathies

544

1299

2.76

93.28

1.9

1.8

4.43

3.69

mg/l

2.43

514

1233

Other septicaemia

341

971

3.42

93.23

2.1

1.7

5.82

3.66

mg/l

6.59

320

920

Certain infectious and parasitic diseases

638

1266

2.54

86.24

2.0

1.6

4.28

3.17

mg/l

6.15

600

1214

L01XX Other antineoplastic agents

121

164

7.75

84.87

2.1

2.0

3.53

4.24

mg/l

1.47

121

158

Heart failure, not strict

587

1614

2.49

83.38

2.1

1.8

5.55

3.23

mg/l

15.72

558

1538

Codes for special purposes

422

1543

2.76

80.43

2.1

1.8

4.38

3.81

mg/l

1.70

407

1451

Provisional assignment of new diseases of uncertain etiology

421

1540

2.75

80.17

2.1

1.8

4.37

3.81

mg/l

1.64

406

1448

Chronic kidney disease

288

834

3.43

79.65

2.2

1.7

10.31

3.32

mg/l

28.26

266

780

Abnormal findings on examination of blood, without diagnosis

417

1390

2.78

79.41

1.6

1.9

4.06

4.00

mg/l

0.09

393

1319

Other pulmonary diagnosis

506

932

2.74

78.84

2.0

1.5

4.10

3.38

mg/l

2.32

480

889

Thrombocytopenia, unspecified

121

181

6.93

77.41

1.5

2.0

4.76

4.67

mg/l

0.05

113

174

Gout

291

762

3.41

77.34

2.3

1.8

5.37

4.07

mg/l

3.28

280

718

Acute renal failure

224

585

3.89

74.94

2.3

1.7

8.85

3.23

mg/l

16.87

215

552

ILD differential diagnosis

494

926

2.69

74.58

1.9

1.5

4.15

3.38

mg/l

2.46

470

883

Excluding asthma or asthma-COPD overlap

496

932

2.68

74.56

2.0

1.5

4.15

3.38

mg/l

2.48

470

889

Osteopathies and chondropathies

449

1632

2.59

74.37

2.4

1.8

3.90

3.85

mg/l

0.07

430

1549

COPD differential diagnosis

493

927

2.68

74.01

1.9

1.5

4.15

3.38

mg/l

2.49

469

884

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

520

1949

2.41

73.40

1.9

3.77

3.99

mg/l

0.55

502

1848

Gout, FINNGEN

291

917

3.21

72.55

2.3

1.7

5.37

4.14

mg/l

3.09

280

864

Implicit viral Sepsis

199

498

4.06

70.64

2.5

1.7

5.62

3.45

mg/l

4.24

186

470

Viral Sepsis

199

499

4.05

70.45

2.5

1.7

5.62

3.45

mg/l

4.26

186

471

760

1871

2.11

68.97

2.3

1.6

4.05

3.68

mg/l

1.15

715

1791

Disorders of calcium metabolism

106

157

6.99

68.46

2.5

1.8

6.70

3.81

mg/l

4.82

149

Autoimmune diseases

700

1656

2.16

67.13

1.9

3.84

3.77

mg/l

0.14

659

1580

Implicit bacterial Sepsis

341

1076

2.84

66.91

2.1

1.7

6.41

3.55

mg/l

10.13

320

1023

Viral pneumonia

141

283

5.08

66.17

2.9

1.6

4.30

4.03

mg/l

0.28

131

271

Reimbursement for rheumatic diseases

435

1784

2.45

65.24

1.9

3.30

3.86

mg/l

2.21

416

1700

Implicit viral Sepsis

254

793

3.24

64.60

2.4

1.8

5.28

3.58

mg/l

3.89

239

750

Implicit Sepsis

524

1732

2.30

64.31

2.1

1.8

5.70

3.27

mg/l

13.20

497

1651

Implicit Sepsis

551

1810

2.24

63.26

2.1

1.8

5.55

3.18

mg/l

13.47

525

1727

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

641

1979

2.12

62.70

2.1

1.8

3.99

3.62

mg/l

1.09

612

1883

Malaise and fatigue

338

987

2.78

62.45

1.6

1.9

4.39

3.78

mg/l

1.41

315

934

Implicit bacterial Sepsis

354

1153

2.68

61.87

2.0

1.7

6.43

3.52

mg/l

11.00

333

1096

Hypercalcemia

116

7.78

60.62

2.5

1.7

6.14

3.78

mg/l

3.42

110

Disorders of mineral metabolism

115

210

5.62

60.15

2.4

1.9

6.42

3.72

mg/l

4.80

106

200

Bronchitis

693

2162

2.03

59.97

2.4

1.7

3.99

3.70

mg/l

0.83

650

2064

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

250

534

3.20

56.24

1.8

1.5

4.02

3.72

mg/l

0.45

234

505

Used for control exclusion in common control thyroid runs

636

1547

2.09

56.01

1.9

4.00

3.74

mg/l

0.60

601

1476

Heart failure,strict

405

1182

2.44

55.84

1.9

1.8

5.36

3.42

mg/l

9.66

380

1124

Certain disorders involving the immune mechanism

185

520

3.61

55.74

2.0

1.9

4.65

4.02

mg/l

0.86

179

498

Malignant neoplasm of skin

254

558

3.14

55.71

1.8

1.5

4.25

3.65

mg/l

1.18

241

528

Dialysis, with operation codes

140

323

4.42

55.57

2.2

1.8

13.22

3.07

mg/l

18.48

135

307

Condition for Implicit Sepsis (Organ dysfunction codes)

549

1829

2.13

55.48

2.1

1.8

5.60

3.16

mg/l

13.94

524

1744

Condition for Implicit Sepsis (Organ dysfunction codes)

556

1832

2.10

54.14

2.0

1.8

5.25

3.11

mg/l

12.55

529

1748

Asthma, unspecified (mode), excluding more controls

294

805

2.75

52.52

1.7

1.5

3.51

3.18

mg/l

0.62

286

769

Other malignant neoplasms of skin (=non-melanoma skin cancer)

227

493

3.18

50.82

1.7

1.5

4.13

3.71

mg/l

0.73

212

465

Opioids

570

1425

2.09

50.71

2.0

1.7

3.94

3.56

mg/l

1.02

540

1357

Basal cell carcinoma, including avohilmo

227

497

3.17

50.64

1.8

1.5

4.03

3.70

mg/l

0.53

212

468

Abnormal findings on diagnostic imaging of lung

375

1554

2.33

50.25

1.9

1.8

3.98

4.14

mg/l

0.29

361

1469

All influenza

195

605

3.26

50.23

3.5

1.6

4.15

3.70

mg/l

0.53

177

575

Glomerular diseases

174

506

3.49

49.84

2.2

1.8

9.08

3.81

mg/l

11.40

162

481

Examination and observation for other reasons

389

941

2.41

49.64

2.0

1.7

3.51

3.86

mg/l

0.79

373

886

Abnormalities of breathing

546

1542

2.07

48.84

1.8

3.89

3.61

mg/l

0.67

514

1471

Basal cell carcinoma

218

480

3.16

48.63

1.8

1.5

4.19

3.75

mg/l

0.73

202

452

Dyspnoea

585

2204

1.97

48.61

1.9

1.8

4.31

3.65

mg/l

2.29

549

2108

Other heart diseases, wide

545

1634

2.05

48.29

2.0

1.9

4.05

3.24

mg/l

3.57

526

1553

Asthma, unspecified (mode)

303

891

2.57

47.86

1.7

1.5

3.50

3.41

mg/l

0.13

292

852

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

111

157

5.08

46.19

1.8

1.6

4.25

3.26

mg/l

1.13

105

150

Metabolic disorders

594

1865

1.95

46.09

2.0

1.8

4.55

3.44

mg/l

5.44

561

1773

Other heart diseases

280

688

2.67

45.80

2.1

1.8

4.31

2.69

mg/l

6.17

271

654

Viral infections characterized by skin and mucous membrane lesions

302

1249

2.44

45.08

2.2

1.8

3.65

3.76

mg/l

0.17

284

1183

Nephropathy related operations

131

338

3.95

44.87

2.2

1.8

13.68

3.82

mg/l

16.13

126

322

Asthma, excluding more controls

375

834

2.35

44.48

1.6

1.5

3.51

3.17

mg/l

0.76

358

796

Cardiovascular diseases (excluding rheumatic etc)

334

787

2.45

44.43

1.9

1.7

4.03

2.59

mg/l

5.30

324

746

Tramadol

466

1373

2.09

43.90

1.8

1.7

3.90

3.59

mg/l

0.71

441

1308

Certain infectious and parasitic diseases

421

953

2.22

43.33

1.9

1.7

4.55

3.06

mg/l

6.43

397

913

Any death

447

1551

2.08

42.64

2.3

1.8

5.48

3.54

mg/l

8.21

419

1489

Medical observation and evaluation for suspected diseases and conditions

408

946

2.22

41.99

2.0

1.7

3.64

3.86

mg/l

0.40

385

890

Heart failure, strict

419

1405

2.12

41.86

1.9

1.8

5.39

3.79

mg/l

7.03

394

1334

Acute upper respiratory infections of multiple and unspecified sites

458

1676

2.03

41.76

2.4

1.7

3.84

3.62

mg/l

0.43

433

1600

Asthma

392

922

2.24

41.63

1.6

1.5

3.50

3.39

mg/l

0.20

374

881

Viral infections characterized by skin and mucous membrane lesions

527

2364

1.91

41.51

2.0

1.8

3.64

3.73

mg/l

0.20

496

2256

Headache

333

1167

2.29

41.51

2.0

1.8

3.34

3.53

mg/l

0.34

312

1111

Polyneuropathies and other disorders of the peripheral nervous system

190

651

2.96

41.48

2.0

1.8

4.12

4.38

mg/l

0.28

184

612

Other disorders of lacrimal gland

269

1101

2.47

41.27

1.9

3.74

3.95

mg/l

0.33

259

1044

Other acute lower respiratory infections

349

1525

2.19

40.63

2.4

1.8

4.23

3.92

mg/l

0.64

329

1437

Codeine

513

1411

1.98

40.55

1.7

3.79

3.55

mg/l

0.53

483

1345

Asthma (mode)

383

926

2.22

40.34

1.7

1.5

3.38

mg/l

0.00

364

883

Parasetamol

409

956

2.18

40.29

1.9

1.6

4.22

3.62

mg/l

1.33

390

901

All-cause Heart Failure

409

1389

2.09

39.68

1.9

1.8

5.44

3.79

mg/l

7.20

385

1318

Acute upper respiratory infections

624

2116

1.82

39.65

2.3

1.7

3.89

3.77

mg/l

0.25

588

2019

Glomerular disorders in diseases classified elsewhere

118

311

3.86

39.27

2.2

1.7

9.74

4.02

mg/l

8.46

111

299

Dorsalgia

585

1679

1.87

39.11

1.9

1.8

3.48

3.72

mg/l

0.68

552

1591

Diseases of the respiratory system

357

795

2.26

38.29

2.0

1.5

4.23

3.41

mg/l

2.16

341

760

Zoster [herpes zoster]

161

528

3.09

38.01

2.3

1.9

3.62

4.27

mg/l

1.53

151

502

Cardiovascular diseases

293

650

2.43

37.72

1.8

3.89

2.48

mg/l

4.63

285

612

Hypertensive diseases (excluding secondary)

287

692

2.42

37.42

1.9

1.8

5.03

2.69

mg/l

8.05

277

658

Asthma (only as main-diagnosis), excluding more controls

330

834

2.27

37.26

1.7

1.5

3.21

3.17

mg/l

0.08

312

796

Disorders of lacrimal system

303

1364

2.23

37.13

1.9

3.69

3.89

mg/l

0.37

291

1293

Low back pain

450

1657

1.96

36.74

1.9

1.8

3.41

3.73

mg/l

0.81

424

1572

Enterocolitis due to Clostridium difficile

108

281

3.91

36.61

3.6

1.8

5.74

4.42

mg/l

0.98

100

270

Chronic apical periodontitis

653

2116

1.76

36.60

2.1

1.8

3.93

3.69

mg/l

0.62

624

2007

Other soft tissue disorders, not elsewhere classified

551

1759

1.84

35.88

1.9

3.48

3.82

mg/l

1.00

525

1670

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

175

276

3.19

35.70

1.8

4.31

3.15

mg/l

1.77

169

260

Other arthritis (FG)

208

821

2.55

34.54

2.2

1.8

4.29

3.79

mg/l

0.64

196

778

Oedema, not elsewhere classified

193

728

2.63

34.09

2.1

1.8

4.23

3.87

mg/l

0.50

185

687

Bacterial intestinal infections, IBD co-morbidities

149

498

3.03

34.07

3.2

1.8

5.09

4.07

mg/l

1.01

136

476

Other bacterial intestinal infections

145

478

3.07

33.96

3.3

1.6

5.13

4.01

mg/l

1.11

131

456

Intestinal infectious diseases

547

2336

1.78

33.86

2.3

1.8

4.38

3.60

mg/l

2.53

513

2226

Acute bronchitis

269

1187

2.24

33.11

2.3

1.7

4.33

4.05

mg/l

0.43

252

1114

Venous thromboembolism

360

1755

1.99

32.71

2.4

1.7

4.08

3.96

mg/l

0.19

344

1660

Complications of surgical and medical care, not elsewhere classified

581

2291

1.74

32.63

1.8

1.9

4.05

3.70

mg/l

0.93

556

2175

Dermatitis

389

2020

1.93

32.34

1.8

1.9

3.88

3.73

mg/l

0.27

367

1923

Other and unspecified dermatitis

334

1655

2.03

32.16

1.8

3.85

3.70

mg/l

0.25

316

1572

Other diseases of intestines

592

1935

1.75

32.14

1.9

1.8

4.13

3.53

mg/l

2.09

552

1847

Heart failure and antihypertensive medication

189

458

2.72

32.14

2.1

2.0

5.66

3.05

mg/l

6.73

180

441

Pain, not elsewhere classified

163

591

2.78

32.07

1.5

1.9

3.97

3.67

mg/l

0.33

156

561

Asthma (only as main-diagnosis)

335

922

2.11

31.94

1.7

1.5

3.20

3.39

mg/l

0.49

315

881

Other and unspecified polyneuropathies, also in other diseases

159

575

2.80

31.57

2.0

1.8

4.01

4.49

mg/l

0.55

153

539

Bacterial pneumoniae

251

985

2.26

31.12

3.4

1.6

4.52

3.61

mg/l

1.99

240

933

Hypertension, essential

440

1331

1.88

30.26

1.9

4.70

2.99

mg/l

8.74

422

1273

Bacterial pneumonia (organism specified)

298

1306

2.08

30.23

3.3

1.6

4.48

4.02

mg/l

0.84

286

1226

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

116

356

3.24

29.92

1.9

1.5

4.02

3.96

mg/l

0.05

108

335

Non-ischemic cardiomyopathy

222

765

2.36

29.64

2.0

1.9

4.80

3.77

mg/l

3.32

214

727

DVT of lower extremities and pulmonary embolism

285

1375

2.08

29.25

2.5

1.8

4.08

4.11

mg/l

0.03

270

1300

Osteoporosis

191

736

2.45

28.65

2.0

1.7

3.91

4.26

mg/l

0.51

181

692

L04AA Selective immunosuppressants

163

628

2.62

28.60

1.8

1.9

5.26

3.69

mg/l

2.46

152

600

Erysipelas

380

1541

1.89

28.48

1.8

1.7

4.41

3.38

mg/l

4.24

359

1468

Heart failure and bmi 25plus

235

697

2.29

28.42

1.9

4.92

4.11

mg/l

1.69

220

666

Spondylopathies

468

1566

1.79

28.17

1.9

1.8

3.77

mg/l

0.01

446

1486

Diseases of the musculoskeletal system and connective tissue

260

579

2.26

28.13

2.1

1.7

4.27

3.77

mg/l

0.72

251

542

Codeine or tramadol medication

633

2101

1.65

28.09

1.8

3.70

3.77

mg/l

0.16

599

2000

Pain in limb

462

1739

1.78

28.06

1.8

1.9

3.56

3.83

mg/l

0.65

446

1652

Other diseases of pleura

308

1357

2.00

27.96

1.9

1.8

4.77

4.10

mg/l

1.41

295

1281

Diarrhoea and gastroenteritis of presumed infectious origin

394

1950

1.83

27.38

2.1

1.7

4.35

3.59

mg/l

2.00

371

1852

Diseases of the skin and subcutaneous tissue

545

1597

1.72

27.23

1.9

1.8

3.88

3.72

mg/l

0.32

522

1511

Erysipelas

305

1365

1.99

27.20

1.7

4.31

3.48

mg/l

2.90

288

1299

Hypertensive diseases

434

1350

1.82

27.19

1.8

1.9

4.70

2.97

mg/l

8.68

418

1292

Symptoms and signs involving the skin and subcutaneous tissue

413

2269

1.79

27.11

2.1

1.8

3.26

3.85

mg/l

3.30

394

2157

Other bacterial intestinal infections

162

639

2.56

27.10

3.0

1.7

4.92

3.91

mg/l

1.12

148

607

Hypertension

433

1350

1.82

26.92

1.8

1.9

4.70

2.97

mg/l

8.68

417

1292

Other respiratory diseases principally affecting the interstitium

146

550

2.69

26.86

1.9

1.8

4.65

4.62

mg/l

0.02

136

522

ILD, hospital admissions

128

452

2.87

26.68

1.7

1.9

4.38

4.71

mg/l

0.28

120

428

Other specified/unspecified arthritis

181

758

2.41

26.62

2.3

1.9

4.24

3.77

mg/l

0.61

171

722

Zoster [herpes zoster]

316

1616

1.94

26.61

2.0

1.8

3.72

4.01

mg/l

0.77

298

1532

Interstitial lung disease

129

460

2.84

26.40

1.8

4.37

4.68

mg/l

0.26

121

436

Interstitial lung disease endpoints

129

460

2.84

26.40

1.8

4.37

4.68

mg/l

0.26

121

436

Myeloproliferative diseases

236

3.67

26.40

1.5

1.8

3.13

4.47

mg/l

3.96

230

Other interstitial pulmonary diseases

129

461

2.83

26.30

1.8

4.37

4.67

mg/l

0.25

121

439

Acute sinusitis

284

1320

2.00

26.11

2.4

1.7

3.78

3.49

mg/l

0.49

265

1262

Disorders of eyelid, lacrimal system and orbit

495

2219

1.70

26.10

1.9

3.62

3.84

mg/l

0.60

473

2111

Gastrointestinal diseases

289

694

2.09

26.08

2.0

1.6

4.21

3.11

mg/l

3.03

280

657

Pain in throat and chest

448

1524

1.77

26.03

1.9

1.8

3.51

3.64

mg/l

0.28

426

1454

Fentanyl

238

3.61

25.94

3.0

1.7

4.23

4.29

mg/l

0.03

229

ILD, hospital admission 2, with pulmonary infections

193

3.88

25.10

1.8

1.5

4.72

3.93

mg/l

0.57

183

Glomerulonephritis

254

3.48

25.03

2.3

1.9

8.01

4.27

mg/l

4.01

247

Bacterial pneumonia, not elsewhere classified

229

947

2.14

25.01

3.4

1.6

4.24

3.64

mg/l

1.31

220

896

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

230

664

2.20

24.89

2.0

1.8

3.37

2.71

mg/l

1.65

219

632

Lower back pain or/and sciatica

577

2331

1.62

24.71

2.0

1.8

3.50

3.80

mg/l

0.95

544

2223

Persons with potential health hazards related to communicable diseases

195

869

2.24

24.28

1.9

1.7

3.49

3.48

mg/l

0.01

189

826

Other dorsopathies, not elsewhere classified

533

1679

1.67

24.21

1.9

1.8

3.56

3.72

mg/l

0.38

502

1591

Other special examinations and investigations of persons without complaint or reported diagnosis

352

946

1.89

24.15

2.1

1.7

4.19

3.86

mg/l

0.55

335

890

Pulmonary heart disease, diseases of pulmonary circulation

218

1031

2.13

23.99

2.3

1.8

4.39

4.24

mg/l

0.17

206

972

Diseases of salivary glands

209

978

2.15

23.66

2.0

1.9

3.43

3.78

mg/l

0.52

200

928

Other/unspecified dorsalgia

224

1075

2.08

23.15

1.9

1.8

3.54

3.82

mg/l

0.48

217

1013

Other specific joint derangements/joint disorders

370

1333

1.80

23.12

1.7

1.9

3.24

3.60

mg/l

0.79

348

1268

Symptoms and signs involving the circulatory and respiratory systems

512

1545

1.66

23.00

1.9

1.8

3.74

3.62

mg/l

0.25

484

1474

Syncope and collapse

223

922

2.08

22.56

1.8

1.9

4.16

3.81

mg/l

0.48

209

872

Pain (limb, back, neck, head abdominally)

386

1081

1.79

22.52

1.8

4.24

3.95

mg/l

0.48

368

1026

Dermatitis and eczema

591

2328

1.58

22.47

1.8

1.9

3.96

3.70

mg/l

0.67

561

2216

Neurological diseases, wide definition

129

227

2.86

22.34

2.1

1.5

3.72

2.96

mg/l

1.05

124

216

ILD, hospital admissions 1, main diag only

113

412

2.78

22.27

1.7

1.8

4.55

4.61

mg/l

0.04

106

391

Other disorders of bone

128

499

2.59

22.05

2.7

1.7

3.37

3.80

mg/l

0.65

123

478

Valvular heart disease excluding rheumatic fever

273

1023

1.94

21.88

1.8

2.0

4.30

3.60

mg/l

1.70

264

971

Other viral diseases

163

710

2.30

21.84

2.6

1.8

3.86

3.69

mg/l

0.19

156

675

Pain in joint

307

1049

1.87

21.74

1.7

1.8

3.38

3.86

mg/l

0.95

289

997

Non-rheumatic valve diseases

272

1020

1.93

21.72

1.8

2.0

4.30

3.57

mg/l

1.83

263

968

Diseases of oesophagus, stomach and duodenum

570

2163

1.58

21.68

1.8

1.9

4.07

3.59

mg/l

1.51

542

2058

Intestinal infectious diseases

614

2264

1.55

21.48

2.2

1.8

4.19

3.62

mg/l

1.78

580

2156

Cardiac arrhythmias

313

1106

1.85

21.28

1.9

3.81

3.06

mg/l

2.83

306

1055

Pulmonary embolism

198

949

2.10

21.12

2.4

1.8

4.21

4.24

mg/l

0.02

188

895

Implicit fungal Sepsis

153

3.99

21.10

1.6

1.7

6.83

3.64

mg/l

2.38

148

Pulmonary heart disease

198

960

2.08

20.50

2.4

1.8

4.21

4.28

mg/l

0.07

188

904

Complications of medical and surgical care

414

2310

1.65

20.45

1.9

4.13

3.73

mg/l

0.90

397

2195

Diseases of pulp and periapical tissues, including avohilmo

553

1818

1.58

20.41

1.8

4.06

3.75

mg/l

0.76

526

1720

Other viral diseases

194

928

2.08

20.34

2.4

1.8

3.68

3.52

mg/l

0.22

184

885

Symptoms and signs concerning food and fluid intake

199

3.50

20.21

1.4

1.9

3.93

4.10

mg/l

0.12

189

Nutritional anaemias

290

1556

1.80

19.76

1.5

1.8

4.78

3.98

mg/l

1.70

268

1471

Hypothyroidism, strict autoimmune

359

1377

1.72

19.42

1.9

4.11

3.86

mg/l

0.42

340

1310

Acute tubulo-interstitial nephritis

332

1671

1.72

18.90

2.0

1.8

4.82

2.91

mg/l

9.82

314

1585

Arthropathies

437

1359

1.63

18.45

1.8

4.01

3.65

mg/l

0.73

413

1291

Dorsopathies

516

1681

1.56

18.26

1.9

1.8

3.70

3.72

mg/l

0.03

491

1593

Disorders of other endocrine glands

239

1269

1.86

18.10

1.9

1.8

5.44

3.71

mg/l

3.25

231

1198

Bleeding

457

2068

1.58

17.92

1.7

1.9

4.86

3.69

mg/l

4.04

424

1973

Dental operations

327

962

1.75

17.87

1.7

4.47

4.04

mg/l

0.74

311

914

All influenza (not pneumonia)

317

2.80

17.79

3.0

1.7

4.01

3.80

mg/l

0.17

306

Rheumatoid arthritis

190

854

2.01

17.70

1.4

1.8

3.64

3.94

mg/l

0.49

178

810

Infections of the skin and subcutaneous tissue

311

1812

1.71

17.59

2.3

1.8

4.31

3.59

mg/l

1.64

298

1722

Factors influencing health status and contact with health services

145

309

2.36

17.57

1.9

1.5

4.93

3.35

mg/l

2.75

140

290

Other disorders of skin and subcutaneous tissue

387

2136

1.62

17.44

2.1

1.8

4.14

3.83

mg/l

0.57

375

2025

Diseases of the eye and adnexa

386

1170

1.66

17.21

1.9

1.8

4.10

3.51

mg/l

1.29

367

1123

Benign neoplasms

489

1741

1.55

17.08

1.8

1.9

3.66

3.77

mg/l

0.22

464

1661

Endocrine, nutritional and metabolic diseases

387

1191

1.65

17.03

1.8

1.9

4.47

2.96

mg/l

6.28

367

1136

Use of hypnotics and sedatives

557

2133

1.50

16.94

2.0

1.8

3.73

3.76

mg/l

0.06

529

2036

Nausea and vomiting

161

762

2.08

16.87

1.9

1.8

4.64

4.01

mg/l

0.78

150

722

malignant neoplasm of male genital organs

100

226

2.71

16.84

1.5

1.3

4.03

4.15

mg/l

0.09

218

Malignant neoplasm of digestive organs

130

453

2.27

16.33

1.7

1.4

3.99

3.87

mg/l

0.12

122

427

Iron deficiency anaemia

242

1340

1.79

16.15

1.6

1.8

4.95

4.04

mg/l

1.59

222

1266

Diverticular disease of intestine

402

1618

1.59

16.14

1.9

1.8

4.41

3.74

mg/l

2.12

380

1544

Malignant neoplasm of prostate, including Hilmo

100

225

2.65

16.12

1.5

1.3

4.16

4.19

mg/l

0.02

217

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

509

2170

1.51

16.01

2.1

1.8

3.80

mg/l

0.00

485

2065

Antihypertensive medication - note that there are other indications

259

763

1.80

15.83

1.9

4.25

2.62

mg/l

4.87

246

732

Disorders of lipoprotein metabolism and other lipidaemias

428

1702

1.56

15.79

1.7

1.8

4.55

3.56

mg/l

3.52

409

1614

Disorders of gallbladder, biliary tract and pancreas

522

2210

1.49

15.72

1.9

1.8

3.90

3.73

mg/l

0.40

494

2107

Cerebrovascular diseases (FINNGEN)

160

550

2.07

15.52

1.9

1.8

4.39

2.83

mg/l

2.90

153

523

Care involving use of rehabilitation procedures

312

1746

1.65

15.42

2.0

1.8

4.36

3.22

mg/l

3.13

301

1655

Other joint disorders

407

1359

1.58

15.41

1.8

3.27

3.65

mg/l

0.97

382

1291

Diagnoses used for exclusion with ILD

159

797

2.01

15.20

1.6

1.8

4.01

4.32

mg/l

0.41

149

754

Other and unspecified iron deficiency

194

1039

1.88

15.19

1.6

1.9

5.15

4.07

mg/l

1.57

179

983

Constipation

475

2196

1.50

14.97

2.2

1.8

4.03

3.76

mg/l

0.60

443

2095

Persons encountering health services for examination and investigation

315

946

1.67

14.71

1.9

1.7

4.46

3.86

mg/l

1.11

303

890

Cough

216

1146

1.79

14.49

2.2

1.8

3.47

3.69

mg/l

0.38

199

1090

Gingivitis and periodontal diseases

523

1830

1.48

14.46

1.8

3.97

3.81

mg/l

0.30

491

1743

Other arrhythmias

314

1457

1.63

14.45

1.6

1.9

3.90

3.34

mg/l

1.43

303

1384

Urticaria and erythema

193

1055

1.84

14.22

1.9

3.46

3.69

mg/l

0.30

183

1000

Nerve, nerve root and plexus disorders

542

2298

1.45

13.99

1.8

3.69

3.80

mg/l

0.24

515

2186

Diseases of oral cavity, salivary glands and jaws

296

915

1.67

13.78

1.7

1.8

4.62

4.07

mg/l

0.99

280

864

Malignant neoplasm of prostate

218

2.53

13.69

1.5

1.3

4.17

4.24

mg/l

0.05

210

Hyperlipidaemia, other/unspecified

220

1162

1.75

13.63

1.5

1.8

4.73

3.73

mg/l

1.86

214

1095

Fibromyalgia

205

2.96

13.49

2.0

1.7

2.23

3.49

mg/l

4.60

197

Complications of procedures, not elsewhere classified

408

2250

1.50

13.46

1.8

1.9

4.02

3.72

mg/l

0.64

391

2139

Other skin changes

116

542

2.16

13.46

2.9

1.8

3.20

4.47

mg/l

4.37

109

516

Diarrhoea and gastroenteritis of presumed infectious origin

496

2249

1.46

13.44

2.0

1.8

4.10

3.61

mg/l

1.33

471

2141

AV-block

104

404

2.27

13.36

1.4

1.8

4.51

4.00

mg/l

0.59

374

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

328

2073

1.57

13.36

1.9

4.08

3.79

mg/l

0.47

312

1967

Symptoms and signs involving the digestive system and abdomen

502

1721

1.46

13.24

1.9

1.8

3.95

3.74

mg/l

0.46

472

1642

Haemorrhage from respiratory passages

190

950

1.81

13.19

1.7

1.8

3.90

4.04

mg/l

0.20

185

900

Persons encountering health services in other circumstances, wide

584

2124

1.42

13.08

1.7

1.9

4.13

3.66

mg/l

1.38

555

2015

Disorders of lens

374

1522

1.54

13.05

2.1

1.8

4.63

3.71

mg/l

2.49

351

1457

General examination and investigation of persons without complaint and reported diagnosis

295

944

1.63

12.80

1.7

4.06

3.86

mg/l

0.23

279

888

Other CVD (FINNGEN)

219

2.64

12.77

2.2

1.9

4.03

3.08

mg/l

0.95

209

Other disorders of fluid, electrolyte and acid-base balance

171

887

1.84

12.72

2.0

1.8

5.64

3.81

mg/l

3.33

158

836

Exposure to unspecified factor

488

2446

1.44

12.60

1.8

1.9

3.82

3.73

mg/l

0.19

460

2332

Ischemic heart diseases

434

1765

1.48

12.57

1.8

1.9

4.65

3.56

mg/l

3.67

417

1689

Fracture of lumbar spine and pelvis

128

637

2.02

12.52

1.6

1.8

4.52

4.46

mg/l

0.05

121

600

Periodontitis

492

2294

1.44

12.49

1.8

1.9

4.03

3.75

mg/l

0.63

466

2190

Disorders of parathyroid gland

124

610

2.02

12.16

1.7

1.8

7.27

4.23

mg/l

3.51

118

577

Symptoms and signs involving the nervous and musculoskeletal systems

305

1969

1.55

12.05

1.8

1.9

3.58

3.85

mg/l

0.49

292

1861

Spondylosis

284

1461

1.59

12.03

1.6

1.8

3.80

3.82

mg/l

0.02

273

1386

Diseases of the digestive system

250

1534

1.63

12.02

2.0

1.8

5.02

3.94

mg/l

1.78

232

1452

Asthma, hospital admission 2, infections

293

1836

1.57

12.01

1.9

3.95

3.86

mg/l

0.11

274

1738

Asthma-related infections

293

1836

1.57

12.01

1.9

3.95

3.86

mg/l

0.11

274

1738

Presence of other functional implants

316

1413

1.56

11.89

2.0

1.8

3.82

4.06

mg/l

0.46

297

1346

Symptoms and signs involving the urinary system

396

2053

1.47

11.72

1.8

1.9

4.19

3.84

mg/l

0.67

371

1955

Rheumatoid arthritis, including avohilmo

210

1249

1.69

11.67

1.5

1.9

3.56

3.97

mg/l

0.96

196

1184

Urticaria

149

806

1.86

11.47

1.9

1.8

3.47

3.64

mg/l

0.16

143

764

217

1297

1.67

11.45

2.0

1.9

3.79

mg/l

0.01

202

1232

Mycoses

149

807

1.86

11.45

2.6

1.9

4.22

4.05

mg/l

0.14

141

765

Disorders of the thyroid gland

471

2156

1.43

11.44

1.9

4.09

3.72

mg/l

0.86

448

2050

Chronic periodontitis, including avohilmo

485

2300

1.42

11.42

1.8

1.9

4.05

3.74

mg/l

0.70

460

2195

Dialysis

3.90

11.40

2.6

1.6

18.82

2.92

mg/l

9.90

Soft tissue disorders

488

1766

1.43

11.33

1.7

1.9

3.79

3.82

mg/l

0.05

465

1675

Gout, unspecified

121

616

1.98

11.23

1.7

6.01

4.38

mg/l

2.32

114

578

Vocal cord dysfunction

260

2.46

11.10

2.0

1.8

4.61

3.38

mg/l

0.77

252

Gonarthrosis [arthrosis of knee](FG)

352

1363

1.50

11.06

1.8

3.81

3.72

mg/l

0.14

333

1299

Seropositive rheumatoid arthritis

128

665

1.93

11.04

1.5

1.8

3.88

3.95

mg/l

0.07

120

627

Diseases of pulp and periapical tissues and dental caries

326

1093

1.53

10.82

1.8

4.53

4.02

mg/l

0.97

309

1038

Other functional intestinal disorders

234

1351

1.61

10.79

2.1

1.8

4.42

3.75

mg/l

1.09

220

1282

Benign neoplasm of colon, rectum, anus and anal canal

344

2021

1.48

10.76

1.7

1.9

3.78

4.04

mg/l

0.59

326

1926

Conjunctivitis (acute, non atopic)

143

779

1.84

10.68

2.7

1.9

3.64

3.62

mg/l

0.02

130

743

Conduction disorders

154

692

1.81

10.63

1.4

1.9

4.35

3.75

mg/l

1.02

142

649

Diseases of arteries, arterioles and capillaries

356

1788

1.47

10.60

1.7

1.9

4.86

3.90

mg/l

2.51

343

1692

Heart failure and coronary heart disease

246

1092

1.60

10.57

1.8

1.9

5.55

4.04

mg/l

3.86

227

1040

Hyperparathyroidism

107

527

2.02

10.56

1.7

1.8

7.67

4.25

mg/l

3.38

101

500

Other diseases of hard tissues of teeth

277

910

1.58

10.53

1.9

1.8

4.39

4.08

mg/l

0.43

261

860

Senile cataract

339

1391

1.50

10.53

2.1

1.8

4.50

3.79

mg/l

1.60

315

1330

Dental caries, including avohilmo

370

1281

1.48

10.50

1.8

4.28

3.98

mg/l

0.54

353

1221

Diseases of the ear and mastoid process

552

2019

1.37

10.41

1.9

3.89

3.65

mg/l

0.53

520

1927

Type 2 diabetes, wide definition

414

1854

1.43

10.36

1.7

1.9

4.89

3.56

mg/l

4.66

390

1771

Gout, idiopatic and unspecified

146

812

1.81

10.36

1.6

1.8

5.69

4.32

mg/l

2.28

139

767

Hypothyroidism, other/unspecified

434

2020

1.42

10.24

1.9

4.01

3.70

mg/l

0.63

414

1915

Hard cardiovascular diseases

421

1762

1.43

10.22

2.0

1.9

4.55

3.57

mg/l

3.12

404

1686

Pure hypercholesterolaemia

364

1628

1.46

10.21

1.7

1.8

4.59

3.61

mg/l

3.00

348

1540

Other noninfective gastroenteritis and colitis

131

707

1.86

10.20

1.7

1.9

4.09

3.95

mg/l

0.11

121

674

DVT of lower extremities

110

561

1.97

10.20

3.0

1.8

3.63

4.32

mg/l

1.18

104

532

Diseases of liver

186

1113

1.68

10.18

1.7

1.8

4.18

3.79

mg/l

0.52

175

1055

Colorectal cancer

316

2.30

10.16

1.8

1.5

4.41

4.13

mg/l

0.20

300

Abnormalities of heart beat

173

995

1.71

10.14

1.7

1.8

3.73

3.86

mg/l

0.17

163

944

Noninfectious colitis NAS

357

2.23

10.08

1.7

1.8

3.86

4.29

mg/l

0.30

346

Weight loss

270

2.43

10.08

1.5

1.8

3.95

4.46

mg/l

0.40

260

Caries of dentine, including avohilmo

392

1383

1.45

10.07

2.0

1.8

4.27

3.94

mg/l

0.63

375

1318

Herpesviral [herpes simplex] infections

121

641

1.90

10.02

2.1

1.8

3.46

3.59

mg/l

0.16

113

609

Other diseases of urinary system

489

1987

1.39

9.92

1.8

1.9

3.87

3.71

mg/l

0.34

458

1895

Undetermined asthma, excluding more controls

218

2.58

9.91

1.5

1.4

3.51

3.19

mg/l

0.20

209

Other disorders of ear

457

2150

1.39

9.90

1.8

1.9

3.92

3.77

mg/l

0.29

432

2048

Symptoms and signs involving cognition, perception, emotional state and behaviour

470

2317

1.39

9.86

1.7

1.9

3.61

3.74

mg/l

0.27

434

2218

Malignant melanoma of skin

136

3.03

9.79

1.8

1.5

5.44

4.48

mg/l

0.41

131

Abdominal and pelvic pain

476

1721

1.39

9.70

1.9

1.8

3.81

3.74

mg/l

0.14

451

1642

Genitourinary diseases

257

820

1.57

9.66

1.9

1.8

5.06

2.70

mg/l

8.50

246

778

Persons encountering health services in other circumstances

199

1224

1.62

9.59

1.8

1.9

3.36

3.63

mg/l

0.57

187

1154

Disorders of sclera, cornea, iris and ciliary body

266

1760

1.52

9.54

1.9

1.8

3.53

3.77

mg/l

0.41

250

1674

Cholelithiasis, broad definition with cholecystitis

433

2091

1.40

9.52

2.0

1.8

3.75

mg/l

0.01

407

1996

Hypothyreosis and Thyroxine purchase for inclusion criteria

445

2104

1.39

9.49

1.9

4.01

3.72

mg/l

0.57

423

1996

Other disorders of urethra and urinary system

342

1703

1.45

9.47

1.8

1.9

4.02

3.74

mg/l

0.54

326

1617

Persons encountering health services for other counselling and medical advice, not elsewhere classified

528

2120

1.36

9.34

1.6

1.9

4.13

3.67

mg/l

1.37

511

2013

Missing teeth due to accident, extraction or parodontitis

310

2001

1.46

9.29

2.2

1.8

4.17

3.89

mg/l

0.41

296

1903

Coronary revascularization (ANGIO or CABG)

398

1728

1.41

9.24

1.8

1.9

4.70

3.59

mg/l

3.65

383

1652

Percutaneous Coronary Intervention

397

1728

1.41

9.15

1.8

1.9

4.68

3.59

mg/l

3.50

381

1652

Asthma, hospital admissions 3, pneumonia

189

1167

1.62

9.12

2.1

1.9

4.34

4.20

mg/l

0.15

178

1100

Asthma-related pneumonia or sepsis

189

1167

1.62

9.12

2.1

1.9

4.34

4.20

mg/l

0.15

178

1100

Cholelithiasis

415

2058

1.39

9.06

1.9

1.8

3.73

3.78

mg/l

0.08

391

1964

Asthma-related pneumonia

188

1164

1.62

8.98

2.1

1.9

4.33

4.20

mg/l

0.13

177

1097

Other gastritis (incl. Duodenitis)

125

695

1.81

8.94

1.8

5.31

4.13

mg/l

1.29

118

655

Sleep apnoea, including avohilmo

487

2225

1.36

8.94

1.8

1.9

3.75

3.77

mg/l

0.03

458

2131

Sleep apnoea

465

2208

1.37

8.93

1.7

1.9

3.79

3.78

mg/l

0.01

438

2116

Other reaction to severe stress, and adjustment disorders

159

947

1.68

8.91

2.0

1.8

3.85

3.40

mg/l

0.49

150

906

Candidiasis

357

2.14

8.87

2.5

1.8

4.91

4.00

mg/l

0.56

343

Methotrexate

345

2.16

8.80

1.8

2.0

3.60

3.82

mg/l

0.24

331

Non-allergic asthma (mode), excluding more controls

348

2.14

8.77

1.9

1.5

3.65

3.22

mg/l

0.69

332

GI-bleeding

168

1027

1.64

8.55

2.0

1.7

5.45

4.25

mg/l

1.42

155

971

Other CVD

110

599

1.85

8.45

2.0

1.8

4.54

4.67

mg/l

0.09

103

561

Noninfective enteritis and colitis

220

1437

1.53

8.39

1.8

3.95

3.75

mg/l

0.25

203

1359

Hypertensive heart and/or renal disease

143

621

1.73

8.37

1.8

1.9

5.65

3.51

mg/l

5.28

136

589

Undetermined asthma

238

2.36

8.29

1.5

3.51

3.50

mg/l

0.00

227

Neurological diseases

390

1403

1.40

8.29

1.9

3.96

3.83

mg/l

0.19

371

1332

Paracetamol or NSAID medication

157

2.28

8.28

1.7

1.6

3.39

4.20

mg/l

0.69

151

Disease of hard tissues of teeth, NOS

255

882

1.52

8.27

1.8

3.30

4.01

mg/l

2.70

245

836

Other symptoms and signs involving the nervous and musculoskeletal systems

205

1325

1.55

8.26

1.7

1.8

3.27

3.82

mg/l

1.04

198

1251

Asthma (diagnoses ohter than nonallergic)

405

2458

1.37

8.25

1.7

1.9

3.52

3.77

mg/l

0.60

386

2335

Arthrosis

328

1256

1.44

8.21

1.8

4.13

3.74

mg/l

0.67

312

1193

Disorders of conjunctiva

371

2159

1.38

7.99

2.1

1.8

3.58

3.65

mg/l

0.10

343

2067

Injuries to the abdomen, lower back, lumbar spine and pelvis

192

1221

1.56

7.94

1.7

1.8

4.07

4.00

mg/l

0.07

183

1152

335

2.10

7.83

1.6

1.9

3.68

3.48

mg/l

0.17

321

Meniscus derangement

260

1190

1.48

7.81

1.9

1.8

3.24

3.79

mg/l

2.03

251

1133

Sciatica+with lumbago

236

1462

1.49

7.79

1.9

1.8

3.33

3.69

mg/l

0.98

224

1385

Sulfasalazine

128

748

1.72

7.77

1.4

1.8

3.52

3.68

mg/l

0.17

119

714

Chronic lower respiratory diseases

556

2268

1.31

7.75

1.7

1.9

3.63

3.74

mg/l

0.23

530

2159

Hernia

438

2192

1.34

7.62

1.8

1.9

4.22

3.66

mg/l

1.59

418

2087

Other diseases of the digestive system

164

1028

1.60

7.60

2.0

1.8

5.51

4.27

mg/l

1.43

150

971

Other viral diseases, not elsewhere classified

113

638

1.77

7.59

2.6

1.7

3.21

3.62

mg/l

0.61

106

611

Budesonide

314

2.11

7.51

1.6

1.8

3.17

4.12

mg/l

1.66

304

Non-invasive ventilation

113

573

1.77

7.47

2.8

1.8

4.01

3.25

mg/l

0.71

101

550

Hypothyroidism, strict autoimmune, 3 medication purchases required

393

1959

1.36

7.41

1.9

1.8

4.16

3.73

mg/l

0.96

372

1858

Kela reimbursement Agammaglobulinemia (D80-84)

8.69

7.40

3.6

1.7

4.23

4.78

mg/l

0.14

Use of anticholinesterases

969

0.49

7.36

1.6

1.8

4.26

4.71

mg/l

0.31

906

N06DA Anticholinesterases

969

0.49

7.36

1.6

1.8

4.26

4.71

mg/l

0.31

906

Hypersplenism

16.74

7.34

1.6

1.1

3.16

4.91

mg/l

—

STROKE

274

1299

1.44

7.24

1.8

1.9

4.15

3.52

mg/l

1.31

259

1246

Chronic myeloid leukaemia

21.17

7.22

1.2

2.0

2.55

3.20

mg/l

—

Disturbances of skin sensation

129

772

1.68

7.21

1.6

1.8

3.15

3.80

mg/l

1.15

120

736

Benign neoplasm: Colon

281

1900

1.42

7.19

1.8

1.9

3.79

4.08

mg/l

0.76

266

1808

Hypo-osmolality and hyponatraemia

469

1.88

7.17

2.0

1.9

4.71

4.04

mg/l

0.63

442

Iridocyclitis

114

661

1.73

7.17

1.8

1.9

3.36

4.02

mg/l

1.10

109

629

Actinic keratosis

199

1222

1.51

7.13

1.9

1.8

3.90

4.47

mg/l

1.77

183

1154

Phlebitis and thrombophlebitis (not including DVT)

118

692

1.71

7.13

2.8

1.9

3.92

4.05

mg/l

0.12

109

656

Intracranial trauma

251

1216

1.45

7.11

2.1

1.8

3.99

3.77

mg/l

0.35

238

1156

Dysphagia

128

769

1.67

7.07

1.9

1.8

3.55

4.15

mg/l

1.14

122

730

Coxarthrosis [arthrosis of hip](FG)

254

1237

1.45

7.05

1.7

1.8

3.61

3.88

mg/l

0.74

239

1176

Ischaemic heart disease, wide definition

386

1776

1.35

6.93

1.8

1.9

4.61

3.64

mg/l

2.95

366

1700

Major coronary heart disease event

411

1859

1.34

6.92

1.8

1.9

4.81

3.65

mg/l

3.86

395

1773

213

1322

1.48

6.91

1.9

1.8

3.92

4.38

mg/l

1.27

194

1252

Emergency coronary revascularization (for ACS)

419

1917

1.33

6.87

1.8

1.9

4.67

3.74

mg/l

2.88

402

1823

Non-allergic asthma (mode)

383

1.95

6.87

1.9

1.6

3.65

3.54

mg/l

0.13

365

Abnormality of white blood cells, not elsewhere classified

7.45

6.79

1.2

1.4

3.42

2.85

mg/l

0.53

Malignant neoplasm of breast

131

513

1.67

6.74

1.5

1.6

2.94

2.99

mg/l

0.07

126

485

Other diseases of lip and oral mucosa

196

1316

1.49

6.73

1.9

1.8

3.66

3.77

mg/l

0.13

189

1245

Hypotension

504

1.81

6.72

2.2

1.7

4.28

4.65

mg/l

0.31

477

Cystitis

397

1768

1.34

6.70

1.8

1.9

3.57

3.73

mg/l

0.32

375

1682

Malignant neoplasm of breast, HER2-negative, including Hilmo

132

515

1.66

6.70

1.5

1.6

2.94

2.98

mg/l

0.07

127

487

Malignant neoplasm of breast, including Hilmo

132

515

1.66

6.69

1.5

1.6

2.94

2.98

mg/l

0.07

127

487

Benzodiazepine use

462

2443

1.30

6.69

1.9

1.8

3.59

3.78

mg/l

0.46

425

2340

Skin changes due to chronic exposure to nonionizing radiation

201

1251

1.49

6.65

1.9

1.8

3.90

4.46

mg/l

1.76

184

1183

Disorders of choroid and retina

394

2114

1.33

6.51

1.7

1.9

4.66

3.80

mg/l

2.07

367

2015

Gonarthrosis

294

1201

1.40

6.49

1.8

3.90

3.75

mg/l

0.20

278

1143

Sleep disorders (combined)

522

2136

1.28

6.45

1.7

1.9

3.71

3.80

mg/l

0.19

487

2040

Other antidepressants

485

1919

1.30

6.42

1.8

3.39

3.91

mg/l

2.02

452

1840

Other intervertebral disc disorders

363

1627

1.35

6.42

1.8

3.54

3.75

mg/l

0.49

345

1544

Conjunctivitis

322

1982

1.36

6.40

2.1

1.8

3.50

3.61

mg/l

0.15

298

1895

Conductive and sensorineural hearing loss

384

1955

1.33

6.34

1.7

1.9

3.98

3.90

mg/l

0.11

363

1860

Temporomandibular joint disorders, including avohilmo

179

1181

1.50

6.25

2.0

1.9

2.77

3.52

mg/l

3.33

163

1130

Malignant neoplasm of pancreas, including Hilmo

3.00

6.22

1.7

1.4

3.61

4.11

mg/l

0.36

Coronary atherosclerosis

318

1480

1.36

6.17

1.8

1.9

4.53

3.77

mg/l

1.78

302

1414

Chronic periodontitis, complicated

269

1930

1.38

6.16

1.6

1.9

4.23

3.79

mg/l

0.67

252

1843

Other diseases of upper respiratory tract

511

2084

1.28

6.16

1.9

1.8

3.68

3.85

mg/l

0.40

485

1981

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

241

1663

1.41

6.15

2.0

1.8

3.65

3.72

mg/l

0.08

225

1584

Myalgia

109

654

1.67

6.11

1.8

1.9

2.88

3.71

mg/l

2.50

100

623

Malignant neoplasm of breast, HER2-negative

127

510

1.63

6.06

1.4

1.6

2.95

2.99

mg/l

0.06

122

482

Other diseases of anus and rectum

145

933

1.56

6.05

2.2

1.8

3.81

4.00

mg/l

0.22

135

885

Dizziness and giddiness

356

2129

1.33

6.05

1.6

1.9

3.61

3.80

mg/l

0.43

329

2038

Sequelae of external causes of morbidity and mortality

128

805

1.60

5.97

2.2

1.8

3.88

4.14

mg/l

0.30

123

765

Disorders of skin appendages

207

1441

1.44

5.92

2.0

1.8

4.16

3.57

mg/l

0.81

199

1362

Coeliac disease

304

1.98

5.86

2.2

1.8

4.01

3.92

mg/l

0.04

294

Diabetic nephropathy, excluding more controls

299

1.91

5.83

1.9

1.6

9.96

3.73

mg/l

5.58

281

Other hearing loss

143

909

1.54

5.79

1.9

1.8

4.61

4.49

mg/l

0.10

132

851

Gastro-oesophageal reflux disease

314

2026

1.34

5.76

1.7

1.9

3.90

3.65

mg/l

0.43

298

1926

Other cataract

219

1166

1.43

5.74

2.2

1.8

4.42

3.90

mg/l

0.79

210

1114

Follow-up examination after treatment for conditions other than malignant neoplasms

179

800

1.48

5.67

2.1

1.7

3.88

3.89

mg/l

0.01

170

752

Colorectal adenocarcinoma

260

2.04

5.62

1.8

1.4

4.42

4.24

mg/l

0.09

247

Candidiasis

132

849

1.56

5.62

2.0

1.8

4.55

3.73

mg/l

0.80

122

801

Other arthrosis

236

1168

1.40

5.59

1.9

4.04

3.77

mg/l

0.36

225

1112

Mycoses

376

2522

1.30

5.56

2.0

1.8

3.80

3.72

mg/l

0.11

354

2404

Iron deficiency anaemia secondary to blood loss (chronic)

455

1.77

5.49

1.4

1.8

4.94

4.32

mg/l

0.44

434

Keratitis

160

1081

1.48

5.42

2.0

1.8

3.74

3.85

mg/l

0.11

149

1022

Hypertensive Heart Disease

120

592

1.59

5.40

1.8

1.9

5.12

3.50

mg/l

3.66

114

561

Alcohol use disorder, ICD-based

1392

0.59

5.37

1.3

1.8

4.85

3.83

mg/l

0.75

1331

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1496

0.61

5.35

1.3

1.8

4.60

3.86

mg/l

0.55

1429

Episodal and paroxysmal disorders

489

1973

1.26

5.35

1.8

1.9

3.66

3.77

mg/l

0.20

464

1876

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

271

2011

1.35

5.34

1.9

4.39

3.82

mg/l

0.99

259

1907

Acute pharyngitis

291

1.95

5.34

2.1

1.9

2.38

3.22

mg/l

2.97

282

Presbycusis

398

1.80

5.28

1.7

1.8

5.10

4.86

mg/l

0.17

370

Angina pectoris

280

1385

1.35

5.26

1.9

4.57

3.79

mg/l

1.74

263

1324

Other or unspecified ileus, impaction or obstruction

544

1.68

5.24

2.0

1.7

4.59

4.10

mg/l

0.42

519

Paralytic ileus and intestinal obstruction

123

795

1.55

5.15

2.2

1.7

4.80

4.05

mg/l

0.79

114

750

Mental and behavioural disorders due to alcohol

113

1677

0.65

5.13

1.3

1.8

4.53

3.80

mg/l

0.70

104

1595

Diaphragmatic hernia

178

1243

1.44

5.12

1.8

1.9

4.92

4.03

mg/l

1.08

172

1174

Obesity related asthma

160

1095

1.47

5.11

1.7

1.9

3.88

3.83

mg/l

0.05

146

1037

Other disorders of bladder

363

1.83

5.10

1.6

1.8

4.26

4.66

mg/l

0.29

346

Asthma, including avohilmo

526

2381

1.24

5.10

1.7

1.9

3.52

3.80

mg/l

0.82

498

2266

Disorders of vitreous body

246

1755

1.36

5.05

2.0

1.8

4.43

3.86

mg/l

0.92

231

1673

Necrosis of pulp, including avohilmo

245

1805

1.36

5.04

1.9

1.8

3.67

3.51

mg/l

0.22

233

1729

Disorders of vitreous body and globe

252

1795

1.35

5.04

2.0

1.8

4.38

3.86

mg/l

0.85

237

1713

Pacemaker

161

1061

1.46

5.00

1.4

1.8

4.49

mg/l

0.00

152

997

In situ neoplasms

178

1250

1.43

4.97

2.0

1.8

4.09

4.11

mg/l

0.02

165

1185

147

1885

0.69

4.95

1.4

1.9

4.71

3.80

mg/l

1.12

137

1789

Ovarian cyst

145

555

1.51

4.93

1.9

1.8

2.99

3.58

mg/l

1.48

134

536

Substance abuse

136

1885

0.68

4.93

1.4

1.9

4.73

3.76

mg/l

1.02

126

1784

Shoulder lesions

348

1628

1.30

4.90

1.8

1.9

3.90

3.92

mg/l

0.03

328

1550

Other diseases of liver

525

1.66

4.88

1.8

1.9

3.74

4.01

mg/l

0.20

504

Chronic ulcer of skin, not elsewhere classified

168

2.22

4.87

2.4

1.6

7.77

4.84

mg/l

1.19

162

Injuries to the thorax

208

1509

1.38

4.81

1.9

1.8

4.24

4.01

mg/l

0.28

194

1430

Other (seronegative) rheumatoid arthritis, wide

582

1.62

4.77

1.4

1.9

3.67

4.07

mg/l

0.64

554

Alcohol use disorder, Swedish definition

129

1745

0.68

4.70

1.5

1.9

4.78

3.80

mg/l

1.06

120

1659

Acne

151

2.26

4.70

1.8

1.7

3.44

3.00

mg/l

0.17

144

Mental and behavioural disorders due to psychoactive substance use

144

1925

0.69

4.66

1.4

1.9

4.69

3.75

mg/l

1.06

134

1824

Unspecific neurodegenerative disorder

102

1081

0.64

4.66

1.6

1.8

4.45

4.54

mg/l

0.07

1015

Dementia

110

1154

0.65

4.64

1.5

1.8

4.15

4.45

mg/l

0.31

1090

Concussion

204

1207

1.38

4.63

2.1

1.8

3.67

3.78

mg/l

0.17

193

1148

Chondropathies

397

1.75

4.62

1.9

1.8

2.94

4.14

mg/l

2.68

385

Coxarthrosis

229

1112

1.36

4.62

1.7

1.8

3.58

3.85

mg/l

0.71

214

1055

140

1831

0.69

4.61

1.4

1.8

4.80

3.80

mg/l

1.20

131

1738

Fracture of rib(s), sternum and thoracic spine

140

955

1.47

4.60

2.2

1.8

4.34

4.13

mg/l

0.18

130

909

Calcific aortic valvular stenosis, including rheumatic fever

141

934

1.47

4.55

1.8

5.13

4.56

mg/l

0.62

134

873

Sensorineural hearing loss

357

1904

1.27

4.52

1.7

1.9

3.91

mg/l

0.00

337

1812

Unspecified haematuria

205

1240

1.37

4.51

1.7

1.9

4.70

4.08

mg/l

0.89

190

1177

Degenerative diseases of the nervous system

915

0.61

4.48

1.4

1.8

4.37

4.71

mg/l

0.34

860

Any dementia, excluding more controls

951

0.63

4.46

1.5

1.8

4.24

4.54

mg/l

0.32

894

Gastric ulcer

523

1.63

4.45

2.1

1.9

4.30

4.60

mg/l

0.31

490

Idiopathic gout

264

1.91

4.44

1.4

1.8

5.71

4.41

mg/l

0.77

254

Calcific aortic valvular stenosis, diagnosis (helper)

140

933

1.46

4.42

1.8

5.10

4.57

mg/l

0.55

133

872

Operations 2 for CAVS

140

933

1.46

4.42

1.9

1.8

5.10

4.57

mg/l

0.55

133

872

External causes of morbidity and mortality

289

1102

1.32

4.42

1.8

1.9

4.26

3.51

mg/l

1.62

279

1041

Calcific aortic valvular stenosis

140

934

1.46

4.40

1.9

1.8

5.10

4.56

mg/l

0.55

133

873

Calcific aortic valvular stenosis, operated

140

934

1.46

4.40

1.8

5.10

4.56

mg/l

0.55

133

873

Dermatopolymyositis (FG)

4.73

4.39

2.2

1.8

2.72

2.63

mg/l

0.08

Collagenous colitis

244

1.94

4.39

1.8

1.9

4.57

4.11

mg/l

0.22

237

Insulin medication

275

1772

1.31

4.38

1.9

5.58

3.65

mg/l

5.34

254

1687

Other leukaemias of specified cell type

9.60

4.37

1.9

2.70

3.83

mg/l

—

Any dementia

997

0.64

4.36

1.5

1.8

4.30

4.68

mg/l

0.46

940

Chronic sinusitis

188

1366

1.38

4.34

1.9

1.8

3.22

3.71

mg/l

1.12

175

1299

Varicose veins

287

1669

1.30

4.33

2.1

1.8

4.02

3.93

mg/l

0.12

273

1581

Other disorders of veins

181

1302

1.39

4.32

1.6

1.8

3.59

3.74

mg/l

0.30

173

1235

Coxibs

120

414

1.53

4.30

1.6

1.9

4.08

4.98

mg/l

1.10

112

393

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

9.05

4.30

2.4

1.3

3.29

3.30

mg/l

—

Seropositive rheumatoid arthritis, wide

128

871

1.47

4.29

1.5

1.9

3.88

4.07

mg/l

0.22

120

826

Insulin, combination of fast acting with intermediate-acting or long-acting

275

1934

1.30

4.29

1.9

1.8

5.58

3.79

mg/l

4.69

254

1838

5-aminosalicylic acid

491

1.63

4.25

1.7

1.8

3.77

3.68

mg/l

0.06

470

Deforming dorsopathies

121

816

1.49

4.24

2.2

1.9

3.67

3.85

mg/l

0.18

116

770

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

125

849

1.48

4.24

1.4

1.9

3.91

4.09

mg/l

0.19

117

805

Substance abuse, excluding more controls

136

1659

0.70

4.23

1.4

1.9

4.73

3.73

mg/l

1.08

126

1581

Alzheimer disease, including avohilmo

933

0.63

4.21

1.4

1.8

4.37

4.68

mg/l

0.35

876

Dipeptidyl peptidase 4 (DPP-4) inhibitors

274

1691

1.30

4.17

1.8

1.9

5.39

3.81

mg/l

4.52

256

1613

250

0.28

4.13

1.4

1.6

7.91

4.80

mg/l

—

236

Dementia, including avohilmo

123

1230

0.69

4.13

1.6

1.9

3.98

4.45

mg/l

0.65

111

1163

COPD (mode)

112

584

1.51

4.11

1.5

4.80

3.80

mg/l

1.62

105

556

Functional dyspepsia

119

806

1.48

4.10

1.9

1.8

3.65

3.83

mg/l

0.14

114

764

Irritable bowel syndrome

118

798

1.48

4.10

1.7

1.8

3.23

3.53

mg/l

0.51

108

762

Seropositive rheumatoid arthritis, strict definition

451

1.65

4.07

1.4

1.8

4.19

4.10

mg/l

0.06

433

Any event in hilmo or specialist outpatient

+∞

4.06

1.6

0.0

2.80

—

mg/l

—

Dermatopolymyositis, unspecified

6.68

4.03

2.0

1.4

2.57

4.08

mg/l

—

Asthma, hospital admissions , main diagnosis only

347

2446

1.25

4.00

1.7

1.9

3.22

3.81

mg/l

3.41

325

2329

Fall on same level

496

2231

1.21

3.99

1.8

1.9

4.21

3.59

mg/l

1.91

474

2123

Exclusions for E4_PCOS_CONSORTIUM

282

1368

1.29

3.99

1.8

1.9

3.63

3.56

mg/l

0.08

262

1312

Other/unspecified seropositive rheumatoid arthritis

125

861

1.46

3.97

1.4

1.9

3.91

4.08

mg/l

0.18

117

816

Nontoxic multinodular goitre

613

1.54

3.91

1.9

3.88

3.86

mg/l

0.01

580

Hallux valgus (acquired)

139

702

1.43

3.81

2.0

1.8

3.01

3.83

mg/l

3.05

132

670

Injuries to the head

480

2443

1.21

3.78

2.1

1.8

3.94

3.70

mg/l

0.62

454

2327

Vitreous haemorrhage

280

1.80

3.75

1.7

1.8

7.57

4.33

mg/l

1.64

269

Abnormal involuntary movements

362

1.69

3.74

2.1

1.8

4.12

4.34

mg/l

0.15

347

Other symptoms and signs involving the digestive system and abdomen

462

1.61

3.72

1.8

1.7

2.89

3.80

mg/l

2.95

440

Allergic asthma (mode), excluding more controls

369

1.67

3.72

1.7

1.5

3.28

2.92

mg/l

0.37

352

Accidents

361

1452

1.25

3.69

1.9

1.8

3.99

3.68

mg/l

0.62

344

1374

Visual disturbances and blindness

225

1727

1.30

3.68

1.9

3.89

3.88

mg/l

0.01

210

1632

Propionic acid derivatives

122

418

1.47

3.66

1.9

4.61

4.96

mg/l

0.32

117

396

Trigeminal neuralgia

142

2.13

3.65

1.7

2.35

3.94

mg/l

4.76

136

Intestinal stricture

143

1027

1.40

3.64

2.0

1.8

4.86

4.22

mg/l

0.64

132

972

Gastroduodenal ulcer

120

833

1.44

3.64

1.9

1.8

4.94

4.35

mg/l

0.57

113

777

Alcohol dependence

866

0.59

3.62

1.4

1.9

5.18

3.94

mg/l

0.73

828

Haemorrhoids and perianal venous thrombosis

144

1035

1.39

3.60

1.8

1.7

4.45

3.96

mg/l

0.51

139

978

Excessive attrition of teeth

228

1760

1.30

3.60

2.1

1.8

3.29

3.57

mg/l

0.55

218

1678

Acquired pure red cell aplasia [erythroblastopenia]

8.07

3.59

2.3

1.9

8.89

3.60

mg/l

—

Acne vulgaris

111

2.26

3.54

1.7

1.6

2.89

2.90

mg/l

0.00

106

Alzheimer disease

805

0.63

3.53

1.4

1.8

4.43

4.82

mg/l

0.38

753

Unspecified mental disorder

1222

0.66

3.45

2.0

1.8

3.48

3.69

mg/l

0.19

1163

Kela-code for severe mental illness

1095

0.65

3.37

2.2

1.8

3.22

3.73

mg/l

0.64

1044

Visual disturbances

210

1620

1.30

3.36

2.0

1.9

3.83

3.82

mg/l

0.01

199

1534

Neurotic, stress-related and somatoform disorders

364

2084

1.22

3.34

1.9

3.56

3.59

mg/l

0.03

338

1999

Continuous positive airway pressure

446

1.53

3.30

1.3

1.9

6.21

3.30

mg/l

2.93

431

Injuries to the hip and thigh

209

1461

1.30

3.30

1.9

1.8

4.31

4.07

mg/l

0.36

196

1380

Other external causes of accidental injury

356

1452

1.23

3.26

1.9

1.8

4.02

3.68

mg/l

0.69

340

1374

Viral warts

535

1.52

3.24

1.9

3.59

3.87

mg/l

0.18

511

Convulsions, not elsewhere classified

442

1.57

3.22

1.4

2.0

4.11

3.55

mg/l

0.51

423

Anosmia

4.26

3.22

1.2

2.0

2.90

2.22

mg/l

—

Nontoxic goitre/thyroid nodule

133

968

1.38

3.19

1.7

1.9

3.52

3.92

mg/l

0.61

128

920

Spinal stenosis

224

1330

1.28

3.14

2.1

1.8

4.19

3.95

mg/l

0.33

213

1259

Benign neoplasm of bone and articular cartilage

201

1.85

3.11

1.5

2.0

3.15

4.04

mg/l

1.20

192

Nonsuppurative otitis media

424

1.53

3.10

2.0

1.8

4.42

3.75

mg/l

0.43

404

Diabetic nephropathy

439

1.56

3.10

1.9

1.6

9.96

4.11

mg/l

5.08

408

Excessive, frequent and irregular menstruation

142

568

1.37

3.05

2.0

1.8

3.30

3.59

mg/l

0.36

134

546

Injury, poisoning and certain other consequences of external causes

233

914

1.28

3.04

1.8

1.9

4.03

3.59

mg/l

0.81

224

864

Anxiety disorders

365

2105

1.21

3.04

1.9

3.56

3.58

mg/l

0.03

339

2019

Other inherited muscular atrophy

10.67

3.03

10.0

2.4

1.66

3.36

mg/l

—

Other ill-defined and unspecified causes of mortality

211

1.81

3.00

2.0

1.7

5.33

4.88

mg/l

0.13

203

Other retinal disorders

285

1798

1.24

2.99

1.6

1.9

5.20

3.97

mg/l

2.43

262

1710

Allergic asthma (mode)

393

1.57

2.97

1.7

1.6

3.28

3.07

mg/l

0.20

375

Adverse effects, not elsewhere classified

507

1.50

2.94

1.8

2.73

3.90

mg/l

4.93

489

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

630

1.45

2.93

2.8

1.7

3.92

3.46

mg/l

0.30

605

Osteomyelitis of vertebra

6.95

2.90

1.0

1.7

5.55

5.00

mg/l

—

Mastocytosis

6.83

2.89

1.5

1.8

1.80

3.07

mg/l

—

Organic, including symptomatic, mental disorders

149

1398

0.76

2.85

1.7

1.8

4.87

4.32

mg/l

0.51

136

1323

Suppurative and unspecified otitis media

116

745

1.38

2.84

1.9

1.8

3.29

3.57

mg/l

0.41

109

709

Injuries to the shoulder and upper arm

357

2402

1.20

2.79

2.0

1.8

4.52

3.73

mg/l

2.01

341

2284

Other symptoms and signs involving the urinary system

307

1.64

2.79

2.1

1.8

4.24

4.50

mg/l

0.18

291

Chylothorax

8.78

2.79

1.2

6.26

5.22

mg/l

—

Other or unspecified common variable immunodeficiency

8.62

2.77

1.0

1.2

3.20

2.97

mg/l

—

Malignant neoplasm of accessory sinuses, including Hilmo

8.54

2.76

1.8

2.20

3.45

mg/l

—

Chromophobe cell carcinoma of kidney

8.52

2.76

3.2

1.5

8.74

2.50

mg/l

—

Ill-defined and unknown causes of mortality

232

1.73

2.75

2.1

1.7

5.28

4.96

mg/l

0.10

223

Abnormal serum enzyme levels

131

953

1.34

2.72

1.8

1.9

4.34

4.23

mg/l

0.10

125

902

Subjective visual disturbances

107

774

1.39

2.72

1.9

3.23

3.83

mg/l

1.39

101

733

Inflammatory bowel disease

125

928

1.35

2.70

1.8

1.9

3.96

3.72

mg/l

0.22

114

891

Diseases of middle ear and mastoid

210

1363

1.26

2.70

1.9

1.8

4.20

3.63

mg/l

0.71

199

1288

Procreative management

114

693

1.37

2.70

1.9

1.8

3.27

3.58

mg/l

0.39

109

668

Type of accident

116

852

1.36

2.69

2.0

1.9

4.43

3.83

mg/l

0.51

109

812

Depression or dysthymia

300

1359

1.22

2.67

1.9

1.8

3.98

3.91

mg/l

0.08

285

1305

Polyuria

100

719

1.39

2.65

1.6

1.8

3.42

4.37

mg/l

2.13

681

Other abnormal uterine and vaginal bleeding

463

1.43

2.64

2.0

1.9

3.20

3.79

mg/l

1.15

446

Diabetic retinopathy, excluding more controls

383

1.42

2.63

1.8

1.7

6.72

3.77

mg/l

2.63

363

Volume depletion

228

1.72

2.62

1.7

1.8

6.79

4.13

mg/l

1.37

215

Supplementary factors related to causes of morbidity and mortality classified elsewhere

123

917

1.34

2.60

2.0

1.9

4.65

3.77

mg/l

0.82

116

875

Other specified/unspecified soft tissue disorders

127

1.98

2.60

1.7

2.0

4.45

3.93

mg/l

0.22

121

Inguinal hernia

249

1349

1.24

2.60

1.9

3.93

3.92

mg/l

0.01

238

1281

Later onset COPD, excluding more controls

394

1.47

2.59

1.5

1.6

4.95

3.88

mg/l

1.30

369

Dentofacial anomalies [including malocclusion]

261

1713

1.22

2.58

1.9

2.95

3.51

mg/l

1.76

245

1641

Fracture of femur

114

762

1.36

2.57

2.1

1.8

4.78

4.58

mg/l

0.19

108

719

Ovarian dysfunction, other/unspecified

7.27

2.56

1.0

1.3

2.08

2.47

mg/l

—

Lung diseases due to external agents

394

1.53

2.55

1.9

1.7

4.01

4.62

mg/l

0.80

372

Cholecystectomy

307

2207

1.20

2.52

1.9

1.8

3.68

3.84

mg/l

0.28

289

2103

Insulin, intermediate and long-acting

232

1834

1.23

2.48

1.8

5.83

3.81

mg/l

4.43

213

1742

Retention of urine

151

956

1.30

2.47

1.6

1.8

4.53

4.17

mg/l

0.35

143

908

Anxiety disorders, excluding more controls

353

1936

1.19

2.47

1.9

1.8

3.60

3.56

mg/l

0.05

328

1854

Symptoms and signs involving speech and voice

143

1100

1.30

2.46

1.7

1.8

3.65

3.98

mg/l

0.41

135

1039

Somatoform disorder

430

1.49

2.45

1.8

2.84

3.92

mg/l

3.19

416

Other and unspecified disorders of vitreous body

188

1476

1.26

2.45

1.9

3.77

3.93

mg/l

0.22

178

1406

Schizophrenia

431

0.53

2.44

2.7

1.9

2.70

4.01

mg/l

3.43

415

Obesity due to excess calories

187

1490

1.26

2.43

1.6

1.9

4.60

3.46

mg/l

2.24

176

1421

Preparatory care for dialysis

124

1.95

2.41

2.2

2.1

16.77

4.39

mg/l

5.72

119

Ulcerative colitis

690

1.38

2.40

1.9

3.96

3.83

mg/l

0.09

660

Restrictive cardiomyopathy

6.45

2.39

5.4

1.3

3.58

2.87

mg/l

—

Allergic urticaria

182

1.76

2.39

1.9

3.90

3.59

mg/l

0.12

174

Other and unspecified diseases of spleen

6.41

2.39

3.0

1.7

6.34

4.00

mg/l

—

Seminoma of testis

6.33

2.38

1.2

1.5

4.66

2.65

mg/l

—

Corneal ulcer

492

1.45

2.35

1.7

3.59

3.98

mg/l

0.49

473

Polycystic ovarian syndrome, consortium definition

260

1268

1.22

2.33

2.0

1.9

3.16

3.38

mg/l

0.53

244

1211

Presence of cardiac and vascular implants and grafts

189

1122

1.25

2.33

1.4

1.7

4.57

4.18

mg/l

0.53

179

1065

Cerebrovascular diseases

332

1971

1.18

2.31

1.9

4.26

3.91

mg/l

0.67

314

1875

Cholecystitis

404

1.49

2.30

1.9

1.7

5.32

4.54

mg/l

0.43

378

Diabetes mellitus

422

2122

1.16

2.29

1.7

1.9

4.49

3.42

mg/l

4.19

395

2030

IBD patients in KELA-register

612

1.39

2.28

1.6

1.8

3.63

3.83

mg/l

0.14

589

Hyperplasia of prostate

166

740

1.28

2.27

2.1

1.8

4.28

4.00

mg/l

0.33

157

705

Other and unspecified primary disorders of muscles

3.96

2.26

3.0

1.6

2.29

3.02

mg/l

—

Lumbar disc prolapse

249

1577

1.21

2.26

1.8

3.42

3.72

mg/l

0.73

239

1497

Traumatic subdural haemorrhage

381

1.49

2.26

1.5

1.8

5.87

4.61

mg/l

0.92

357

Other headache syndromes

165

1308

1.26

2.25

1.6

1.9

2.75

3.67

mg/l

6.87

157

1249

Antenatal screening

286

0.59

2.18

2.3

1.8

3.47

2.72

mg/l

0.47

278

Intracranial injury

236

1846

1.21

2.18

2.1

1.8

4.03

3.82

mg/l

0.37

221

1749

Oxicams

389

1.37

2.17

1.8

1.9

3.86

5.07

mg/l

1.31

370

Diabetes, varying definitions

419

2123

1.16

2.17

1.7

1.9

4.48

3.43

mg/l

4.12

392

2031

Insulin, fast-acting

142

1112

1.28

2.16

1.8

5.97

3.80

mg/l

2.75

129

1051

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

106

1.96

2.16

2.1

2.86

2.88

mg/l

0.01

101

Urticaria due to cold and heat

4.34

2.16

1.5

1.7

3.23

2.84

mg/l

—

Retinal detachments and breaks

159

1268

1.26

2.11

1.8

4.17

4.02

mg/l

0.15

151

1200

Other disorders of conjunctiva

429

1.45

2.10

1.9

4.34

4.22

mg/l

0.07

409

Allergic conjunctivitis

208

1663

1.22

2.10

1.6

1.9

3.34

3.54

mg/l

0.30

191

1592

Crohn disease

331

1.51

2.10

1.4

1.9

4.73

4.06

mg/l

0.29

320

Other and unspecified nerve root and plexus disorders, also in other diseases

588

1.38

2.10

2.0

1.9

3.37

3.88

mg/l

0.40

558

Atopic dermatitis, strict definition with reimbursement

641

1.36

2.10

1.8

3.32

3.31

mg/l

0.01

607

Fissure and fistula of anal and rectal regions

699

1.35

2.10

1.7

1.8

3.46

3.60

mg/l

0.11

665

Defects in the complement system

5.07

2.08

2.4

2.1

4.44

4.88

mg/l

—

Seminoma of testis, including Hilmo

5.05

2.07

1.2

1.4

4.66

2.63

mg/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

197

1566

1.22

2.07

1.7

1.9

3.32

3.50

mg/l

0.26

181

1499

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

390

1.47

2.05

1.5

1.8

4.81

4.23

mg/l

0.33

376

COPD, hospital admissions 1, only main diagnosis

1069

0.75

2.05

1.5

1.8

4.90

4.34

mg/l

0.66

1007

Voice disturbances

111

850

1.31

2.04

1.7

1.8

3.48

3.93

mg/l

0.58

105

805

Other viral hepatitis

132

1.83

2.03

2.0

1.6

4.33

3.73

mg/l

0.24

127

Inflammatory bowel disease, strict (require KELA)

626

1.36

2.03

1.6

1.8

3.63

3.93

mg/l

0.22

603

Leiomyoma of uterus

237

1113

1.21

2.03

1.7

1.9

3.01

3.53

mg/l

1.88

220

1066

Chronic gastritis

116

896

1.30

2.00

1.3

1.8

4.39

4.25

mg/l

0.11

108

842

Irregular menses

159

1005

1.25

1.99

2.2

1.9

2.98

3.15

mg/l

0.27

149

962

Other disorders of eye and adnexa

368

1.47

1.99

1.5

1.8

3.43

3.91

mg/l

0.49

354

Disorders of synovium and tendon

211

1527

1.21

1.99

1.6

1.9

3.31

3.76

mg/l

1.04

203

1454

Migraine

175

1150

1.23

1.97

2.0

1.9

2.81

3.49

mg/l

1.99

167

1096

Other benign neoplasms of connective and other soft tissue

256

1.57

1.97

1.9

2.87

4.26

mg/l

3.42

246

Artificial joint operation, meniscal resection

395

2228

1.15

1.97

1.9

3.53

3.93

mg/l

1.52

374

2125

Other disorders of pigmentation

105

1.92

1.96

2.1

1.6

2.66

3.76

mg/l

1.67

3.80

1.94

1.8

1.5

4.67

2.83

mg/l

—

Falls/tendency to fall

451

1977

1.14

1.94

1.8

1.9

4.11

3.58

mg/l

1.47

425

1878

Acetic acid derivatives and related substances

104

407

1.33

1.94

1.8

1.9

4.48

5.03

mg/l

0.49

387

Other benign neoplasms of skin

155

1249

1.24

1.91

2.1

1.8

3.45

4.10

mg/l

1.98

147

1183

Internal derangement of knee

138

1094

1.26

1.88

1.6

1.8

3.17

3.68

mg/l

1.01

133

1040

Stroke, excluding SAH

268

1659

1.18

1.88

2.0

1.8

4.68

4.07

mg/l

1.05

250

1576

Anti-inflammatory and antirheumatic products, non-steroids

109

418

1.31

1.87

2.0

1.9

4.24

4.96

mg/l

0.84

103

396

2.87

1.86

1.1

1.7

4.20

2.31

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

129

1.79

1.85

1.7

2.38

2.81

mg/l

0.61

123

Type 2 diabetes

408

2085

1.14

1.84

1.7

1.9

4.54

3.45

mg/l

4.20

382

1995

Stroke, including SAH

280

1732

1.17

1.84

1.9

4.52

4.06

mg/l

0.77

262

1649

Rotator cuff syndrome

257

1561

1.18

1.84

1.8

1.9

3.94

mg/l

0.00

246

1486

Disorders of phosphorus metabolism and phosphatases

4.25

1.83

3.0

1.3

3.14

3.83

mg/l

—

Benign neoplasm: Colon, unspecified

109

847

1.29

1.83

1.8

3.78

4.26

mg/l

0.98

100

806

Selective deficiency of immunoglobulin G [IgG] subclasses

4.23

1.83

1.8

1.5

6.40

3.13

mg/l

—

Acute laryngitis and tracheitis

210

1.60

1.83

1.9

1.7

3.47

3.21

mg/l

0.15

202

Biological medication for rheuma

434

1.41

1.82

1.5

1.8

2.81

3.90

mg/l

2.93

419

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

113

884

1.28

1.80

1.5

1.9

4.19

3.75

mg/l

0.45

103

838

Schizoaffective disorder

183

0.44

1.80

3.1

1.9

2.95

3.89

mg/l

—

176

Cardiac arrest

130

1.72

1.79

1.3

1.8

6.77

3.11

mg/l

0.94

123

Fracture of neck

161

1.68

1.78

2.2

1.9

3.50

4.61

mg/l

1.19

156

Insulin, fast-acting or short human

142

1145

1.24

1.76

1.8

5.97

3.88

mg/l

2.59

129

1083

Chronic rhinitis, nasopharyngitis and pharyngitis

124

985

1.26

1.76

1.8

3.42

3.71

mg/l

0.44

119

934

Alzheimer disease, excluding more controls

433

0.68

1.75

1.4

1.9

4.43

4.35

mg/l

0.05

404

Autoimmune hepatitis

3.38

1.75

3.0

1.1

2.85

3.22

mg/l

—

Benign paroxysmal vertigo

122

968

1.26

1.75

1.7

1.8

3.75

4.13

mg/l

0.45

109

923

Carpal tunnel syndrome

250

1875

1.18

1.75

1.9

1.8

3.84

3.74

mg/l

0.13

240

1788

Pollen allergy

383

1.42

1.73

1.9

1.8

2.94

3.33

mg/l

0.32

367

Oter anti-inflammatory and antirheumatic agents, non-steroids

376

1.32

1.69

1.6

1.9

3.89

5.00

mg/l

1.74

358

Type 2 diabetes, definitions combined

396

2044

1.14

1.69

1.7

1.9

4.26

3.46

mg/l

3.27

373

1957

Disorders of vestibular function (Vertigo)

195

1605

1.20

1.69

1.9

1.8

3.42

4.01

mg/l

1.41

174

1527

Dementia in Alzheimer disease

457

0.66

1.68

1.4

1.7

4.52

5.07

mg/l

0.37

429

Congenital malformations, deformations and chromosomal abnormalities

207

1659

1.19

1.67

1.8

1.9

3.70

3.52

mg/l

0.27

199

1576

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

389

2061

1.14

1.67

1.6

1.9

4.80

3.46

mg/l

5.16

366

1975

Other chronic obstructive pulmonary disease, including avohilmo

171

1702

0.83

1.67

1.5

1.9

4.44

4.09

mg/l

0.54

160

1618

Psoriasis vulgaris

554

1.34

1.65

1.9

1.8

3.03

4.25

mg/l

3.99

532

Other neurological diseases

307

2098

1.15

1.62

1.9

3.66

3.97

mg/l

0.77

292

1994

Glucosamine medication

210

1416

1.18

1.61

1.8

1.9

3.76

4.33

mg/l

1.26

196

1346

Vascular disorders of the intestines

167

1.62

1.58

2.2

1.6

5.61

3.84

mg/l

1.13

161

Melanoma in situ

129

1.72

1.57

1.8

2.0

3.90

4.51

mg/l

0.24

123

Other aneurysm

152

1.65

1.56

1.6

4.96

4.41

mg/l

0.19

146

Diabetic retinopathy

126

631

1.25

1.56

1.8

6.07

4.45

mg/l

1.50

114

595

Noninflammatory disorders of female genital tract

140

570

1.23

1.53

1.8

3.83

3.59

mg/l

0.25

131

548

Acute myringitis

3.38

1.53

8.6

1.6

2.36

2.93

mg/l

—

Atopic dermatitis, strict definition

661

1.29

1.53

1.9

3.35

3.48

mg/l

0.11

629

Other and unspecified effects of external causes

737

1.28

1.53

1.7

1.8

3.00

3.77

mg/l

1.63

705

Exposure to other and unspecified inanimate mechanical forces

169

1.60

1.52

1.6

1.9

3.89

4.01

mg/l

0.05

163

Acute appendicitis, no complications

205

1735

1.18

1.52

1.7

1.8

3.33

3.54

mg/l

0.34

199

1651

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

138

1.67

1.51

1.7

2.38

2.64

mg/l

0.35

132

Type 2 diabetes, strict (exclude DM1)

396

2067

1.13

1.47

1.7

1.9

4.26

3.46

mg/l

3.22

373

1980

Other and unspecified rosacea

235

1.49

1.46

2.1

1.9

3.75

3.91

mg/l

0.09

225

Deviated nasal septum

131

1072

1.22

1.46

1.9

1.8

4.07

3.83

mg/l

0.24

125

1020

Pyogenic arthritis

171

1.58

1.45

3.1

1.9

8.69

4.04

mg/l

1.75

164

Left ventricular outflow tract obstruction, narrow definition

102

1.77

1.44

1.7

2.0

3.53

3.60

mg/l

0.03

Acute inflammation of orbit

3.17

1.44

2.0

1.7

3.20

3.70

mg/l

—

Muscular dystrophy

3.16

1.44

4.4

1.5

1.84

3.84

mg/l

—

Early lumbar disc prolapse operation

213

0.52

1.41

1.8

1.7

3.11

3.30

mg/l

0.08

207

Other vitreous opacities

103

1.76

1.41

3.2

2.1

4.70

3.97

mg/l

0.19

Gonarthrosis,primary

389

2136

1.12

1.40

1.9

3.76

3.90

mg/l

0.26

372

2034

Chronic hepatitis NAS

2.43

1.39

1.6

1.7

4.96

3.46

mg/l

—

Use of memantine

725

0.76

1.39

1.3

1.8

4.19

4.88

mg/l

0.93

676

Use of other anti-dementia drugs

725

0.76

1.39

1.3

1.8

4.19

4.88

mg/l

0.93

676

Asthma/COPD (KELA code 203)

371

2265

1.12

1.39

1.5

1.9

3.69

3.74

mg/l

0.08

355

2156

Ulcer of oesophagus

198

1.52

1.37

1.6

1.7

5.30

4.64

mg/l

0.16

190

Diseases of inner ear

223

1864

1.16

1.37

1.9

1.8

3.34

4.01

mg/l

2.03

202

1778

Achilles tendinitis

281

1.43

1.35

2.0

1.8

3.22

4.14

mg/l

1.51

269

Other nutritional deficiencies

250

2054

1.15

1.34

1.6

1.9

4.57

3.46

mg/l

2.82

236

1966

Charcot foot

2.16

1.34

1.7

1.4

14.78

3.62

mg/l

—

Other epidermal thickening

113

1.69

1.32

1.6

7.52

4.01

mg/l

0.69

107

Viral hepatitis

160

1.57

1.31

2.0

1.6

4.36

3.84

mg/l

0.21

155

Dislocation, sprain and strain of joints and ligaments of knee

169

1826

0.85

1.29

1.7

1.9

2.93

3.47

mg/l

2.06

163

1738

Dental pulpitis, including avohilmo

345

1995

1.12

1.29

2.0

1.8

3.51

3.47

mg/l

0.05

330

1905

Major coronary heart disease event excluding revascularizations

257

1498

1.14

1.29

1.9

5.04

3.88

mg/l

2.90

239

1428

Periapical abscess

174

1485

1.17

1.28

2.0

1.9

3.95

3.67

mg/l

0.34

169

1413

Diabetes, insulin treatment (Kela reimbursement)

412

2241

1.11

1.27

1.6

1.9

4.86

3.50

mg/l

5.41

387

2141

Benign lipomatous neoplasm

117

966

1.21

1.25

1.5

1.9

4.16

3.99

mg/l

0.15

106

916

Myocardial infarction, without ST-elevation

168

1306

1.17

1.24

1.7

1.8

5.14

4.25

mg/l

1.35

157

1232

Ischaemic Stroke, excluding all haemorrhages

243

1583

1.14

1.24

2.0

1.8

4.76

4.08

mg/l

1.12

227

1499

Urolithiasis

130

1086

1.20

1.24

1.6

1.8

4.01

4.16

mg/l

0.13

122

1030

Cervical disc disorders

137

1150

1.19

1.24

2.3

1.8

3.52

3.80

mg/l

0.38

128

1090

Ehlers-Danlos syndrome

2.65

1.22

1.4

2.1

5.86

3.42

mg/l

—

Leisure time condition

486

1.30

1.22

1.6

1.8

3.88

4.11

mg/l

0.11

463

Acute appendicitis

263

2171

1.13

1.21

1.8

3.76

3.58

mg/l

0.26

254

2067

Disorders of breast

126

1365

0.84

1.21

1.7

1.9

2.99

3.46

mg/l

1.41

118

1307

Endometriosis

114

549

1.22

1.21

1.7

1.8

3.15

3.61

mg/l

0.57

104

529

Migraine without aura

443

1.31

1.20

2.1

1.8

3.18

3.01

mg/l

0.11

423

Later onset COPD

823

0.80

1.20

1.4

1.9

5.25

4.55

mg/l

0.71

770

Glaucoma

239

1806

1.14

1.19

1.9

1.8

3.71

4.15

mg/l

1.09

226

1707

Unspecified fall

190

1620

1.16

1.19

2.1

1.8

4.35

3.95

mg/l

0.52

175

1536

Diabetes medication

414

2221

1.11

1.18

1.6

1.9

4.63

3.45

mg/l

4.57

387

2121

Selective serotonin reuptake inhibitors

408

1924

1.11

1.18

1.8

3.74

3.91

mg/l

0.29

377

1845

Other disorders of eyelid

182

1497

1.16

1.17

1.9

1.8

3.41

4.19

mg/l

3.52

173

1411

COPD related to multimorbidity

124

1245

0.84

1.15

1.3

1.8

4.56

4.30

mg/l

0.35

114

1178

COPD, early/later onset

148

1460

0.85

1.14

1.5

1.8

4.62

4.20

mg/l

0.59

138

1388

Calculus of kidney and ureter

119

997

1.20

1.13

1.6

1.8

3.85

4.21

mg/l

0.44

111

950

Other anxiety disorders

144

1062

1.18

1.12

2.0

1.8

3.25

3.39

mg/l

0.18

132

1013

Disorders of orbit

119

1.60

1.11

1.5

1.7

3.78

3.77

mg/l

0.00

114

Sulfonylureas

107

1023

0.83

1.11

1.8

5.34

4.18

mg/l

1.50

100

965

Congenital malformations, deformations and chromosomal abnormalities

224

1818

1.14

1.10

1.8

1.9

3.62

3.55

mg/l

0.10

216

1728

Macular pucker

530

1.27

1.09

1.7

1.9

4.33

4.37

mg/l

0.03

499

Use of teriflunomide

2.40

1.09

1.0

1.8

2.02

3.35

mg/l

—

Artrosis, including avohilmo

343

1692

1.11

1.07

1.7

1.9

4.00

3.81

mg/l

0.30

327

1615

Myocardial infarction

200

1230

1.14

1.07

1.7

1.9

4.93

3.79

mg/l

2.82

189

1176

Type 2 diabetes, definitions combined, including avohilmo

387

2046

1.10

1.06

1.7

1.9

4.28

3.42

mg/l

3.61

363

1960

Acute and transient psychotic disorders

290

0.65

1.05

2.8

1.8

5.64

3.98

mg/l

0.30

281

Unspecified human immunodeficiency virus [HIV] disease

2.29

1.03

1.0

1.6

3.08

4.13

mg/l

—

Obesity and other hyperalimentation

232

1987

1.13

1.02

1.6

1.9

4.59

3.43

mg/l

2.85

218

1902

COPD, hospital admissions

148

1447

0.86

1.01

1.5

1.8

4.62

4.18

mg/l

0.63

138

1375

Injury of eye and orbit

351

1.31

1.00

2.0

1.8

3.69

4.14

mg/l

0.28

339

Alcohol withdrawal state with delirium

176

0.57

1.00

1.1

1.8

3.45

4.78

mg/l

—

171

Unstable angina pectoris

153

1045

1.16

0.98

2.0

1.9

4.85

4.01

mg/l

1.16

146

992

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

739

0.80

0.97

2.2

1.7

4.00

3.49

mg/l

0.27

707

Degeneration of macula and posterior pole

201

1413

1.13

0.97

1.7

1.9

4.96

4.19

mg/l

1.12

185

1342

Caries of enamel

339

2225

1.10

0.95

1.8

1.9

3.20

3.61

mg/l

1.51

321

2133

Obesity

230

1983

1.12

0.94

1.6

1.9

4.60

3.43

mg/l

2.87

216

1898

Human immunodeficiency virus [HIV] disease

1.90

0.94

1.0

1.8

3.59

3.78

mg/l

—

All anxiety disorders

205

1438

1.13

0.92

2.0

1.8

3.32

3.37

mg/l

0.07

187

1379

Vasomotor and allergic rhinitis

123

1037

1.16

0.91

1.9

3.20

3.58

mg/l

0.60

115

986

Sixth [abducent] nerve palsy

1.63

0.91

1.6

1.8

3.48

3.86

mg/l

0.20

Disorders of ocular muscles, binocular movement, accommodation and refraction

163

1420

1.14

0.89

1.9

1.8

4.22

3.59

mg/l

0.76

156

1339

Persistent delusional disorders

194

0.62

0.89

3.0

1.9

2.98

4.09

mg/l

2.37

188

Benign neoplasm: Adrenal gland

228

1.36

0.88

2.1

1.9

4.70

4.43

mg/l

0.11

221

Poor fetal growth

211

1.38

0.88

1.4

1.7

2.17

2.64

mg/l

1.05

200

Psoriasis

105

895

1.17

0.87

1.8

3.18

3.96

mg/l

3.12

856

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.79

0.84

1.8

1.4

3.06

3.16

mg/l

—

Peripheral artery disease

178

1257

1.13

0.84

1.9

1.8

5.93

4.20

mg/l

2.74

170

1185

Open wound of head

205

1770

1.12

0.84

1.6

1.8

4.17

3.86

mg/l

0.50

192

1677

Use of selegiline

138

0.58

0.83

1.4

2.0

3.01

4.55

mg/l

—

133

Bullous disorders

154

1.43

0.83

2.5

1.8

3.30

4.57

mg/l

1.67

149

Appendicitis, broad definition

277

2282

1.10

0.82

1.8

3.91

3.64

mg/l

0.41

267

2173

Diseases of appendix

279

2292

1.10

0.82

1.8

3.89

3.65

mg/l

0.37

269

2182

Primary coxarthrosis, bilateral

117

1014

1.16

0.81

1.5

1.8

3.75

4.38

mg/l

1.45

109

962

Allergic rhinitis

755

1.18

0.81

1.9

1.8

2.87

3.51

mg/l

1.18

722

Colonic or urogenital fistula

838

1.17

0.80

1.6

1.9

3.81

4.05

mg/l

0.19

796

Other problems related to primary support group, including family circumstances

218

1.34

0.79

3.1

1.7

3.03

3.18

mg/l

0.09

209

Persons encountering health services in circumstances related to reproduction

190

1144

1.12

0.78

2.1

2.0

3.18

3.52

mg/l

0.59

180

1101

Coxarthrosis, primary

250

1924

1.10

0.78

1.7

1.9

3.74

4.11

mg/l

1.26

236

1827

Psychiatric diseases

420

1950

1.08

0.78

1.9

3.81

3.72

mg/l

0.14

394

1866

Other noninflammatory disorders of uterus, except cervix

447

1.19

0.77

2.0

1.9

4.49

3.89

mg/l

0.46

429

Benign neoplasm: Short bones of upper limb

1.77

0.76

2.7

1.8

2.00

3.83

mg/l

—

Diabetic retinopathy, strict definition

403

1.23

0.76

1.6

1.5

8.37

4.23

mg/l

2.02

375

Papulosquamous disorders

148

1312

1.13

0.75

1.9

3.39

3.90

mg/l

1.32

137

1245

Myopia

279

1.29

0.75

2.6

1.9

6.42

3.36

mg/l

1.26

265

Congenital malformations of aortic and mitral valves

1.54

0.75

1.6

2.0

3.16

3.43

mg/l

0.20

Macular cyst

1.57

0.75

1.2

1.9

4.75

4.56

mg/l

0.05

Otorrhagia

2.10

0.75

1.0

1.4

6.40

3.26

mg/l

—

Eustachian salpingitis and obstruction

158

1.39

0.74

1.7

6.53

3.13

mg/l

0.96

149

Single delivery by forceps and vacuum extractor

151

1.32

0.74

1.5

1.6

2.19

2.85

mg/l

1.50

144

Tumor necrosis factor alpha inhibitors

387

1.24

0.74

1.5

1.9

2.67

3.85

mg/l

3.02

378

Diseases of external ear

122

1070

1.14

0.73

2.3

1.8

4.35

3.91

mg/l

0.37

117

1010

Fall on same level involving ice and snow

177

1968

0.90

0.73

1.5

1.9

4.38

3.73

mg/l

0.77

166

1874

Nonalcoholic steatohepatitis

2.02

0.73

1.8

1.5

2.38

2.69

mg/l

—

Contact with other sharp object(s)

136

0.59

0.73

1.5

1.7

2.39

3.81

mg/l

—

131

Fracture of forearm

166

1696

0.90

0.72

1.5

1.9

3.69

3.77

mg/l

0.08

155

1607

Visual field defects

238

1.31

0.70

2.3

1.7

3.07

4.45

mg/l

2.55

231

Nasal polyp

600

1.18

0.70

1.7

3.59

4.08

mg/l

0.48

566

Hallux rigidus

399

0.78

0.70

1.3

1.9

3.36

3.92

mg/l

0.69

381

Normal-pressure hydrocephalus

142

0.63

0.69

2.6

1.7

2.90

4.81

mg/l

—

137

Coxarthrosis, primary, with hip surgery

195

1653

1.10

0.69

1.5

1.9

3.88

4.21

mg/l

0.83

183

1565

Spontaneous abortion

121

925

0.88

0.68

1.7

1.9

3.22

3.19

mg/l

0.03

116

887

Mixed disorders of conduct and emotions, excluding more controls

1.86

0.68

1.4

2.1

2.06

2.11

mg/l

—

Fracture at wrist and hand level

117

1028

1.14

0.68

1.9

1.8

3.77

mg/l

0.00

112

977

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

204

0.69

0.68

1.1

1.8

7.40

3.35

mg/l

0.86

192

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

702

0.84

0.68

2.2

1.8

4.00

3.40

mg/l

0.33

676

Inflammatory diseases of female pelvic organs

201

1341

1.10

0.67

2.0

1.9

3.19

3.40

mg/l

0.38

193

1279

Other (not insulin) diabetes medications

390

2158

1.07

0.67

1.6

1.9

4.35

3.49

mg/l

3.21

367

2063

Alcoholic liver disease

306

0.75

0.66

1.3

1.8

6.32

4.43

mg/l

0.68

295

Female genital prolapse

101

496

1.15

0.66

2.4

1.8

3.18

3.79

mg/l

1.09

478

Contracture of joint

1.73

0.64

2.0

1.8

1.76

2.99

mg/l

—

Triptan medication for migraine, single purchase ok

264

1649

1.08

0.63

1.8

1.9

2.62

3.57

mg/l

8.90

254

1578

Migraine, single triptan purchase ok & required. ICD-code if available is included

264

1649

1.08

0.63

1.8

1.9

2.62

3.57

mg/l

8.90

254

1578

Recurrent or chronic depression

135

847

1.12

0.63

1.6

1.8

3.36

3.60

mg/l

0.24

127

817

Diseases of male genital organs

187

855

1.10

0.62

1.8

4.61

3.89

mg/l

0.95

178

813

Excessive earwax

213

1905

1.09

0.62

1.7

1.9

3.62

3.98

mg/l

0.73

205

1803

Specific development disorders of speech and language

101

0.57

0.62

1.3

2.2

2.77

3.20

mg/l

—

Other papulosquamous disorders

1.67

0.61

2.8

1.7

9.90

4.04

mg/l

—

Systemic atrophies primarily affecting the central nervous system

113

1.42

0.61

5.6

1.8

2.21

4.54

mg/l

4.74

108

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

262

1.26

0.61

1.8

4.89

4.40

mg/l

0.15

254

Contact with other specified venomous animals

0.00

0.60

0.0

1.8

—

3.85

—

Ascites

200

1.30

0.60

1.8

1.7

5.58

4.25

mg/l

0.66

193

Glaucoma suspect

137

1231

1.11

0.60

2.2

1.8

3.38

4.17

mg/l

2.48

131

1160

Ectropion of eyelid

105

1.43

0.60

1.5

1.8

5.00

5.12

mg/l

0.05

Wet age-related macular degeneration

529

1.17

0.60

1.7

1.6

5.73

4.73

mg/l

0.49

493

Benign leiomyoma with endometriosis

477

0.82

0.59

1.9

2.67

3.54

mg/l

1.28

456

Type 1 diabetes, wide definition, subgroup 1

536

1.18

0.59

1.5

2.0

6.94

3.70

mg/l

1.78

512

Diabetic maculopathy, excluding more controls

308

1.24

0.59

1.7

1.8

8.86

4.16

mg/l

1.68

298

Fracture of lower leg, including ankle

176

1909

0.91

0.59

1.8

3.91

3.72

mg/l

0.21

170

1816

Non-selective monoamine reuptake inhibitors

145

1262

1.11

0.58

1.8

3.60

4.02

mg/l

0.88

135

1214

Thyroiditis

184

1.31

0.57

1.3

1.7

5.06

3.69

mg/l

0.33

178

Personality disorders

689

0.86

0.56

1.6

1.8

3.69

3.54

mg/l

0.11

659

Fall on and from stairs and steps

803

1.13

0.55

1.9

3.53

3.98

mg/l

0.60

767

Bicuspidal aortic valve syndrome

1.47

0.54

1.8

1.6

3.27

3.64

mg/l

0.27

Myocardial infarction, strict

178

1160

1.09

0.54

1.7

1.9

5.07

3.83

mg/l

2.81

166

1109

Triptan medication for migraine, min. 3 purchases

172

1201

1.09

0.53

2.0

1.9

2.48

3.34

mg/l

7.01

164

1148

Other obstetric trauma

1.43

0.53

1.4

1.8

1.92

2.99

mg/l

2.17

Alzheimer’s disease (Atypical or mixed), excluding more controls

207

0.77

0.51

1.3

1.8

4.47

4.88

mg/l

0.13

190

Corns and callosities

170

1.30

0.51

2.4

1.7

4.74

4.11

mg/l

0.16

162

Other superficial mycoses

233

1.25

0.50

1.6

1.9

3.44

4.00

mg/l

0.46

224

Dermatophytosis

224

2080

1.08

0.50

2.0

1.8

3.40

3.80

mg/l

0.77

212

1978

Other spirochaetal diseases

1010

0.89

0.50

1.6

1.9

3.35

3.95

mg/l

1.28

961

Polyp of the female genital tract

102

524

1.12

0.48

1.6

1.8

3.38

3.70

mg/l

0.27

504

Misadventures to patients during surgical and medical care

409

1.17

0.48

1.7

1.8

5.71

4.14

mg/l

0.78

392

Lyme disease

996

0.89

0.48

1.6

1.9

3.36

3.98

mg/l

1.30

948

Infections of genitourinary tract in pregnancy

208

1.25

0.47

1.6

1.9

4.98

3.23

mg/l

0.83

198

severe traumatic brain injury, does not include concussion

681

1.13

0.47

1.7

1.8

5.27

4.63

mg/l

0.51

646

Other fall from one level to another

625

1.14

0.47

1.8

1.9

3.82

4.06

mg/l

0.20

594

Anxiety (asthma-related co-morbidities)

204

1466

1.08

0.46

2.0

1.8

3.33

3.40

mg/l

0.09

186

1407

Statin medication

260

1369

1.07

0.46

1.7

1.9

4.25

3.44

mg/l

1.63

252

1307

Other chronic obstructive pulmonary disease

147

1318

0.92

0.46

1.5

1.9

4.63

4.18

mg/l

0.64

137

1246

Other spirochaetal diseases

1002

0.90

0.45

1.6

1.9

3.35

3.97

mg/l

1.33

954

Chronic diseases of tonsils and adenoids

249

1678

0.94

0.45

1.9

3.20

3.54

mg/l

0.78

241

1605

Atopic dermatitis

176

1336

1.08

0.44

1.5

1.9

3.35

3.38

mg/l

0.04

167

1275

Type 1 diabetes

685

1.12

0.43

1.5

1.9

6.88

3.71

mg/l

2.19

650

Postmenopausal bleeding

455

1.11

0.43

1.9

3.83

3.92

mg/l

0.06

438

Insomnia

281

2170

0.94

0.43

1.7

1.9

2.92

3.73

mg/l

4.48

268

2068

Other and unspecified mood [affective] disorders

128

0.70

0.43

1.1

1.6

4.00

3.07

mg/l

—

122

Alzheimer’s disease (Atypical or mixed)

250

0.79

0.43

1.3

1.7

4.47

5.33

mg/l

0.31

235

Delirium, not induced by alcohol and other psychoactive substances

339

1.18

0.43

2.5

1.8

7.09

4.72

mg/l

0.92

320

Spirochaetal infections, other/unspecified

996

0.90

0.42

1.6

1.9

3.35

3.98

mg/l

1.37

948

Juvenile Open Angle Glaucoma

0.00

0.41

0.0

1.9

—

4.07

—

Use of fingolimod

0.00

0.41

0.0

1.8

—

3.43

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.41

0.0

1.4

—

3.75

—

Gender identity disorders

0.00

0.41

0.0

2.0

—

2.65

—

Benign neoplasm: Brain, infratentorial

0.00

0.41

0.0

1.8

—

3.16

—

Use of dimethyl fumarate

0.00

0.41

0.0

2.0

—

3.84

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.41

0.0

1.6

—

2.69

—

Other congenital malformations of heart

0.00

0.41

0.0

1.7

—

2.76

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.5

—

2.90

—

Cleft lip and cleft lip and palate

0.00

0.41

0.0

1.6

—

2.56

—

Contraceptive management

124

797

1.09

0.40

1.9

2.86

3.50

mg/l

1.35

115

772

Lactose intolerance

1.34

0.40

1.7

1.5

3.10

3.17

mg/l

—

Contact with blunt object, undetermined intent

0.00

0.40

0.0

1.5

—

3.03

—

Scarlet fever

0.00

0.40

0.0

1.2

—

2.53

—

Diastasis of muscle

0.00

0.39

0.0

1.8

—

3.59

—

Injuries to the elbow and forearm

227

2118

0.94

0.39

1.6

1.9

3.68

3.71

mg/l

0.05

213

2016

Primary gonarthrosis, bilateral

184

1680

0.94

0.37

1.7

1.8

4.11

4.04

mg/l

0.07

175

1597

Hernia of abdominal wall

170

1590

1.07

0.37

1.9

1.8

4.26

3.88

mg/l

0.54

165

1503

Other menopausal disorders

481

0.90

0.36

1.6

1.8

2.53

3.70

mg/l

4.90

463

Endometriosis of pelvic peritoneum

383

1.15

0.36

2.0

1.7

2.41

3.36

mg/l

2.82

371

Migraine without aura and triptan purchases

346

1.16

0.36

1.9

1.8

2.36

3.07

mg/l

2.33

332

Sequelae of injuries, of poisoning and of other consequences of external causes

696

1.11

0.36

2.0

1.9

3.57

3.92

mg/l

0.51

668

Adhesive capsulitis of shoulder

516

1.12

0.36

1.7

2.0

3.37

3.90

mg/l

0.63

493

Fibroblastic disorders

773

1.10

0.36

1.8

3.49

4.04

mg/l

1.10

730

Other benign neoplasms of uterus

126

1.27

0.35

4.6

1.7

3.48

4.38

mg/l

0.47

120

Glucagon-like peptide-1 (GLP-1) analogues

994

0.91

0.35

1.4

1.9

4.36

3.49

mg/l

1.09

952

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

994

0.91

0.35

1.4

1.9

4.36

3.49

mg/l

1.09

952

Complications predominantly related to the puerperium

651

1.11

0.34

2.2

1.9

2.38

3.08

mg/l

2.19

617

Combinations of oral blood glucose lowering drugs

1024

0.92

0.34

1.7

1.9

4.49

3.90

mg/l

0.69

974

Abscess of anal and rectal regions

200

0.80

0.34

1.6

1.8

2.53

3.70

mg/l

2.76

195

Presbyopia

163

1.23

0.34

2.3

1.8

4.77

3.75

mg/l

0.28

157

Hyperkinetic disorders, excluding more controls

156

1.23

0.33

1.6

2.0

3.56

2.63

mg/l

0.28

148

Graves disease, strict definition

253

0.83

0.33

1.9

1.7

2.68

3.54

mg/l

0.77

244

Type 1 diabetes, wide definition

577

1.11

0.32

1.5

1.9

6.84

3.73

mg/l

1.72

550

Personality disorders, excluding more controls

655

0.90

0.32

1.6

1.8

3.69

3.33

mg/l

0.31

631

Gonarthrosis, primary, with knee surgery

235

1777

1.05

0.32

1.7

1.9

3.95

4.09

mg/l

0.22

224

1689

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

132

0.76

0.32

2.1

1.7

4.80

3.31

mg/l

—

126

Emotional disorders starting during childhood or adolecense, excluding more controls

1.37

0.31

3.3

2.2

1.70

2.25

mg/l

—

Lesion of ulnar nerve

380

1.13

0.31

2.1

1.7

3.43

4.12

mg/l

0.41

363

Central retinal artery occlusion

1.25

0.29

1.3

1.7

3.86

3.98

mg/l

—

Fall on and from ladder

223

1.17

0.28

1.3

1.8

3.46

4.65

mg/l

0.91

215

Ménière disease

280

1.14

0.27

1.9

3.08

4.41

mg/l

2.12

271

Unspecified abortion

118

0.76

0.27

2.0

2.1

2.30

3.27

mg/l

—

113

Sequelae of injuries of head

120

0.75

0.27

1.6

1.9

2.72

4.20

mg/l

—

115

109

887

1.07

0.27

1.7

1.8

5.52

4.60

mg/l

0.71

831

Any mental disorder

444

2150

1.03

0.27

1.9

3.82

3.69

mg/l

0.21

416

2057

Inflammatory disease of cervix uteri

161

0.81

0.27

1.4

1.8

3.01

3.72

mg/l

0.47

153

Other otitis externa (chronic)

168

1.19

0.27

2.3

2.1

6.16

4.51

mg/l

0.34

161

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

141

1.21

0.26

1.4

1.7

4.15

3.74

mg/l

0.18

136

Disorders of speech understanding and production

0.66

0.25

1.2

2.0

3.02

3.66

mg/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

216

1.16

0.25

1.7

1.9

6.51

4.28

mg/l

0.59

208

Foreign body in alimentary tract

123

1.22

0.25

1.7

2.1

3.38

4.62

mg/l

0.87

117

Other degenerative diseases of the nervous system

697

0.93

0.24

1.4

1.9

3.53

4.12

mg/l

0.87

656

Progressive vascular leukoencephalopathy

1.25

0.24

1.2

1.7

3.52

4.94

mg/l

1.60

148

0.81

0.24

1.5

1.7

3.08

2.71

mg/l

0.09

142

Pedal cyclist injured in other and unspecified transport accidents

286

0.87

0.23

1.1

1.8

3.04

4.36

mg/l

2.65

277

Other and unspecified injuries of head

158

0.82

0.23

1.6

1.8

4.12

4.46

mg/l

0.16

152

Diabetic maculopathy

312

1.12

0.23

1.7

1.6

8.63

4.09

mg/l

1.54

292

Nonorganic sleeping disorders, excluding more controls

496

1.09

0.22

1.6

1.8

4.23

3.74

mg/l

0.27

477

Appendectomy

219

2013

1.04

0.22

1.7

1.9

3.22

3.59

mg/l

0.77

212

1916

Hypertrophic disorders of skin

116

1.21

0.22

2.3

1.6

2.29

3.67

mg/l

2.63

111

Effects of other deprivation

0.00

0.21

0.0

1.2

—

2.46

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.7

—

3.25

—

Labyrinthine fistula

0.00

0.21

0.0

1.8

—

3.46

—

Other and unspecified water transport accidents

0.00

0.21

0.0

1.5

—

4.11

—

Internuclear ophthalmoplegia

0.00

0.21

0.0

1.4

—

4.44

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.9

—

3.51

—

Other and unspecified syphilis

0.00

0.21

0.0

1.2

—

2.15

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.8

—

5.63

—

Congenital hydrocephalus

0.00

0.21

0.0

1.4

—

2.58

—

Colour vision deficiencies

0.00

0.21

0.0

1.5

—

4.02

—

Chronic myringitis

0.00

0.21

0.0

1.6

—

4.22

—

Other specified acquired deformities of limbs

0.00

0.21

0.0

1.5

—

2.96

—

Sub-endpoint used in defining T1D endpoints

784

1.07

0.21

1.5

1.8

6.92

3.97

mg/l

2.13

746

Carcinoma in situ of breast

0.00

0.21

0.0

1.3

—

2.86

—

Pectus excavatum

0.00

0.21

0.0

1.3

—

2.55

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.5

—

2.43

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.5

—

4.07

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

0.21

0.0

5.6

—

1.82

—

Prophylactic surgery

0.00

0.21

0.0

2.0

—

2.99

—

Respiratory distress of newborn

0.00

0.21

0.0

6.6

—

1.80

—

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.7

—

3.17

—

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.6

—

2.97

—

Toxic effect of corrosive substances

0.00

0.21

0.0

1.9

—

3.19

—

Congenital malformations of spine and bony thorax

0.00

0.21

0.0

2.0

—

4.16

—

Other and unspecified disorders of adult personality and behaviour

0.00

0.21

0.0

1.3

—

2.28

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

2.6

—

3.54

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.5

—

3.94

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.6

—

3.08

—

Unspecified transport accident

0.00

0.21

0.0

1.5

—

2.66

—

Mild or no visual impairment, binocular

0.00

0.21

0.0

1.5

—

4.22

—

Familial erythrocytosis

0.00

0.21

0.0

1.7

—

4.05

—

ILD medications: nintedanib

0.00

0.21

0.0

1.6

—

4.24

—

Defect, injury or illness of neck

0.00

0.21

0.0

2.0

—

5.36

—

Intentional self-harm by jumping from a high place

0.00

0.21

0.0

2.0

—

4.13

—

Cleft lip and palate

0.00

0.21

0.0

1.8

—

2.78

—

Other specified transport accidents

0.00

0.21

0.0

1.7

—

2.94

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

2.5

—

3.42

—

Other abortion

0.00

0.21

0.0

2.0

—

2.70

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

182

1.15

0.21

2.3

1.8

3.69

4.76

mg/l

0.97

174

Unspecified maternal hypertension

0.00

0.21

0.0

2.0

—

2.12

—

Other and unspecified disorders of psychological development

0.00

0.20

0.0

3.8

—

2.32

—

Behavioural syndromes associated with physiological disturbances and physical factors

327

2249

1.03

0.20

1.8

1.9

3.36

3.71

mg/l

0.78

310

2148

Congenital malformations of spine and bony thorax

0.00

0.20

0.0

1.9

—

3.76

—

Unequal limb length (acquired)

0.00

0.20

0.0

1.6

—

2.48

—

Preterm labour and delivery

683

1.07

0.20

2.0

1.9

2.99

3.24

mg/l

0.39

653

Hypertrophic scar

108

1.20

0.20

2.4

1.7

2.33

3.60

mg/l

2.16

103

Sleep disorders

295

2198

0.97

0.20

1.7

1.9

3.12

3.72

mg/l

2.14

280

2098

Tinnitus

762

1.06

0.19

1.7

1.8

3.22

3.85

mg/l

0.79

722

Agoraphobia

1.18

0.19

1.3

1.7

2.48

2.47

mg/l

—

Disturbance of activity and attention

162

1.15

0.18

1.6

1.7

3.66

2.90

mg/l

0.21

152

Diabetes mellitus in pregnancy

431

0.94

0.18

1.7

1.6

3.33

2.55

mg/l

0.71

410

Chronic mastoiditis

0.75

0.17

2.2

2.1

6.78

4.03

mg/l

—

Unspecified misadventure during surgical and medical care

148

1.15

0.17

1.5

2.0

5.65

4.44

mg/l

0.41

142

Hyperkinetic disorders

173

1.13

0.16

1.6

1.9

3.56

2.85

mg/l

0.20

162

Benign neoplasm of urinary organs

130

1.15

0.15

2.1

2.0

3.39

4.46

mg/l

1.41

125

Transport accidents

152

1261

1.04

0.15

1.6

1.8

3.63

mg/l

0.00

143

1191

Excessive vomiting in pregnancy

178

1.12

0.15

2.0

1.7

2.33

3.18

mg/l

0.97

169

Injuries to the ankle and foot

232

2006

1.03

0.14

2.0

1.8

3.64

3.52

mg/l

0.16

223

1914

Extrapyramidal and movement disorders

127

1318

0.96

0.14

2.1

1.8

3.54

4.18

mg/l

1.52

118

1247

Endometriosis ASRM stages 3,4

635

0.94

0.14

2.0

1.8

3.76

3.28

mg/l

0.32

603

673

0.95

0.14

2.0

1.7

5.17

4.75

mg/l

0.23

628

Persistent mood disorders

552

0.94

0.14

2.2

1.8

3.90

3.96

mg/l

0.04

528

Polycystic ovarian syndrome, broad definition

170

1.12

0.13

2.1

1.7

3.18

2.60

mg/l

0.22

161

Abnormal findings in secretions and smears from cervix uteri vagina vulva

141

1030

1.03

0.13

2.0

1.9

3.29

3.12

mg/l

0.14

133

982

Lichen ruber planus, wide definition including periferal and oral lichen planus

704

0.95

0.13

1.9

1.8

3.43

4.05

mg/l

0.41

669

Nonorganic sleeping disorders

512

1.05

0.12

1.6

1.8

4.23

3.95

mg/l

0.14

493

Infections with a predominantly sexual mode of transmission

881

0.96

0.12

1.8

4.06

3.25

mg/l

0.71

839

Congenital malformations of eye, ear, face and neck

124

1.13

0.11

2.6

1.7

3.07

3.54

mg/l

0.36

119

Endometriosis ASRM stages 1,2

435

1.06

0.11

2.0

1.8

2.41

3.12

mg/l

1.97

417

Hydrocephalus

208

0.91

0.10

1.8

3.17

4.68

mg/l

2.11

201

Injuries to the wrist and hand

358

2520

0.98

0.10

1.8

1.9

3.28

3.80

mg/l

2.13

344

2395

Maternal care related to the fetus and amniotic cavity and possible delivery problems

114

690

0.97

0.10

2.2

1.8

3.04

2.93

mg/l

0.11

109

661

Thyrotoxicosis with toxic multinodular goitre

156

0.90

0.10

1.9

1.7

5.24

4.05

mg/l

0.33

148

Foreign body entering into or through eye or natural orifice

193

1.09

0.10

1.6

1.9

3.70

4.70

mg/l

0.39

187

Pregnancy with abortive outcome

207

1103

0.98

0.09

1.7

1.9

3.58

3.46

mg/l

0.17

195

1052

Mood disorders, excluding more controls

360

2116

1.02

0.09

1.8

1.9

4.08

3.68

mg/l

0.67

339

2024

Open wound of shoulder and upper arm

1.04

0.09

4.0

1.5

3.76

3.09

mg/l

—

Melanocytic naevi of other and unspecified parts of face

145

1.10

0.09

1.4

2.0

3.39

3.86

mg/l

0.29

138

Ovarian dysfunction

116

1.12

0.09

1.5

1.7

2.32

2.45

mg/l

0.20

110

Impingement syndrome of shoulder

797

0.97

0.09

1.6

1.9

3.19

3.82

mg/l

1.48

761

Lichen planus, including avohilmo

594

0.96

0.09

2.0

1.9

3.60

4.12

mg/l

0.26

566

Lactose intolerance, other/unspecified

1.11

0.09

1.8

1.5

2.77

3.27

mg/l

—

Supervision of high-risk pregnancy

272

0.95

0.09

1.8

1.7

2.39

2.75

mg/l

0.78

264

Alcohol-induced chronic pancreatitis

165

0.91

0.08

1.5

1.9

5.25

4.84

mg/l

0.12

160

Depression

346

2310

1.01

0.08

1.9

3.94

3.60

mg/l

0.54

327

2208

123

0.89

0.08

2.5

1.9

2.94

4.54

mg/l

2.32

118

Additional codes for the location of defect, injury or illness

146

1.10

0.08

1.4

2.0

2.89

4.15

mg/l

1.44

139

Postmenopausal atrophic vaginitis

461

0.97

0.07

2.0

1.9

2.51

3.86

mg/l

6.95

445

Polyhydramnios

1.05

0.07

1.4

1.7

2.77

2.57

mg/l

—

Ulcerative proctitis

147

1.09

0.07

1.4

1.8

3.80

3.77

mg/l

0.01

141

Failed induction of labour

1.05

0.07

1.3

1.7

2.68

3.23

mg/l

—

Mental disorders, not otherwise specified

183

0.93

0.06

1.2

1.7

4.16

3.67

mg/l

0.16

177

Primary open-angle glaucoma

107

1057

0.98

0.06

2.2

1.8

3.90

4.62

mg/l

1.52

102

989

Abnormal findings on antenatal screening of mother

111

0.90

0.06

1.6

3.93

2.34

mg/l

—

102

Exposure to other specified factors

251

2332

0.99

0.06

2.0

1.9

3.32

3.69

mg/l

1.12

242

2216

COPD, hospital admission 2, with asthma infections

110

962

0.98

0.06

1.6

1.8

4.99

4.39

mg/l

0.71

101

907

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

185

1485

0.99

0.05

1.9

1.8

3.39

3.54

mg/l

0.16

176

1411

Artificial joint re-operation

198

1.06

0.05

1.5

2.0

4.13

4.36

mg/l

0.18

190

Carcinoma in situ, bladder

100

1.10

0.05

1.7

1.9

3.43

4.78

mg/l

1.42

Carcinoma in situ of other and unspecified sites

110

1.09

0.05

1.7

1.9

3.90

4.79

mg/l

0.61

105

Foreign body in respiratory tract

120

1.08

0.04

1.8

1.9

2.99

3.75

mg/l

0.66

115

Ganglion

594

0.98

0.04

1.5

1.9

3.01

3.69

mg/l

1.02

567

Spirochaetal infections, other/unspecified

251

0.96

0.04

1.5

1.9

3.77

4.27

mg/l

0.31

242

Thyrotoxicosis with diffuse goitre

358

1.03

0.04

1.7

1.9

3.41

3.43

mg/l

0.02

341

Struck by thrown, projected or falling objec

109

0.92

0.04

1.5

1.9

2.51

3.95

mg/l

—

104

Mood disorders

375

2410

1.01

0.03

1.8

4.01

3.66

mg/l

0.60

354

2298

COPD, hospital admissions 3, with asthma pneumonia sepsis

798

0.98

0.03

1.5

1.8

5.11

4.56

mg/l

0.66

751

Medical abortion

201

1099

0.99

0.02

1.7

1.9

3.52

3.47

mg/l

0.06

188

1048

Mood [affective] disorders

374

2410

1.01

0.02

1.8

4.02

3.66

mg/l

0.61

353

2298

Atherosclerosis, excluding cerebral and coronary sclerosis

151

1184

1.01

0.02

2.0

1.9

5.89

4.21

mg/l

2.34

145

1113

Foreign body or object entering through skin

142

1.06

0.02

2.3

1.9

2.87

4.38

mg/l

1.61

136

Postpartum haemorrhage due to anatomy

168

0.95

0.02

2.8

1.7

2.62

2.66

mg/l

0.04

161

Other and unspecified injuries of lower leg

182

1.04

0.02

1.2

1.8

3.12

3.76

mg/l

0.71

175

Blepharochalasis

102

1009

1.01

0.02

1.6

1.9

3.26

4.19

mg/l

3.13

954

Bipolar affective disorders

471

1.02

0.02

2.0

1.9

4.79

3.64

mg/l

0.61

453

Mental and behavioural disorders due to sedatives or hypnotics

147

0.95

0.01

1.3

1.7

6.55

3.73

mg/l

0.57

141

COPD

165

1356

0.99

0.01

1.5

1.9

4.54

4.19

mg/l

0.50

155

1282

Other symptoms and signs involving cognitive functions and awareness

165

1494

1.01

0.01

1.8

1.9

4.12

4.08

mg/l

0.03

153

1421

Polypectomy (DHB20)

186

0.97

0.00

1.7

1.9

4.64

4.58

mg/l

0.01

181

Transient ischemic attack

196

1591

1.00

0.00

1.9

1.8

3.96

4.10

mg/l

0.18

185

1508

Biguanides

359

2187

1.00

0.00

1.6

1.9

4.26

3.58

mg/l

2.18

335

2088

Congenital malformations of the circulatory system

346

1.01

0.00

1.8

1.9

3.44

4.28

mg/l

0.99

333

Other infective otitis externa

159

1.01

0.00

2.6

1.9

3.69

4.28

mg/l

0.29

152

Non-small cell lung cancer, adenocarcinoma, helper endpoint

191

0.99

0.00

1.6

1.8

3.94

4.60

mg/l

0.43

184

COPD-related respiratory insufficiency

365

0.99

0.00

1.8

5.93

4.90

mg/l

0.41

345

Other extrapyramidal and movement disorders in other diseases

755

0.99

0.00

1.9

1.8

3.83

4.15

mg/l

0.33

717

Subarachnoid haemorrhage

305

1.02

0.00

1.2

1.8

3.87

4.55

mg/l

0.60

288

Contact with heat and hot substances

116

1.03

0.00

1.1

2.0

4.07

3.74

mg/l

0.06

111

Inflammatory disorders of breast

124

0.97

0.00

1.2

1.8

2.61

3.47

mg/l

0.87

119

Deep bite

212

0.99

0.00

1.5

2.1

2.78

3.60

mg/l

1.44

205

Lesion of plantar nerve

168

1.01

0.00

2.6

1.8

3.00

3.86

mg/l

1.01

162

Injuries to the knee and lower leg

443

2455

1.00

0.00

1.8

1.9

3.77

3.75

mg/l

0.03

426

2331

Crushed, pushed or stepped on by crowd or human stampede

139

1.01

0.00

2.2

1.9

4.65

3.77

mg/l

0.30

134

Other complications of labour and delivery, not elsewhere classified

158

0.99

0.00

1.5

1.8

2.49

2.66

mg/l

0.11

148

Other peripheral vertigo

276

1.01

0.00

1.4

1.9

3.87

4.37

mg/l

0.22

266

Complications of labour and delivery

190

1059

1.00

0.00

2.0

1.9

3.05

3.35

mg/l

0.59

180

1015

Melanocytic naevi of lower limb, including hip

103

0.97

0.00

3.9

1.7

3.85

mg/l

—

Special screening examination for infectious and parasitic diseases

364

0.99

0.00

1.4

1.7

2.42

3.22

mg/l

2.46

350

Otosclerosis

223

0.99

0.00

2.8

1.9

2.85

4.29

mg/l

2.12

217

Assault by bodily force

143

0.98

0.00

1.1

1.8

4.63

3.45

mg/l

0.30

137

Congenital lactase deficiency

0.00

0.0

1.7

—

2.01

—

Erythrasma

0.00

0.0

1.9

—

5.30

—

Mechanical strabismus

0.00

0.0

1.4

—

2.00

—

Disorder of bilirubin metabolism, other/unspecified

0.00

0.0

1.5

—

4.83

—

Atrioventricular septal defect

0.00

0.0

2.1

—

5.16

—

Behçet disease

0.00

0.0

1.2

—

2.06

—

Exposure to electric transmission lines

0.00

0.0

1.6

—

2.20

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.5

—

2.98

—

Plasmodium falciparum malaria

0.00

0.0

2.0

—

3.10

—

Complicated migraine, drug-induced

0.00

0.0

1.6

—

2.62

—

Thyroid crisis or storm

0.00

0.0

2.0

—

3.67

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.4

—

2.42

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.0

1.6

—

1.94

—

Reduction defects of upper limb

0.00

0.0

1.9

—

3.21

—

Other and unspecified disorders of globe

0.00

0.0

2.0

—

4.08

—

Drug-induced dystonia

0.00

0.0

1.7

—

3.26

—

Thromboangiitis obliterans

0.00

0.0

2.3

—

5.93

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.0

2.3

—

4.00

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

2.8

—

2.18

—

Non-seminoma of testis, including Hilmo

0.00

0.0

1.4

—

2.37

—

Benign neoplasm: Epididymis

0.00

0.0

1.8

—

4.66

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.0

—

2.30

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

2.0

—

3.92

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.9

—

3.09

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

2.2

—

3.42

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.8

—

3.29

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS